Sciatica+with lumbago

M13_SCIATICA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M54.3, M54.4 Hospital discharge: ICD-8 — 7170 Cause of death: ICD-10 — M54.3, M54.4 Cause of death: ICD-8 — 7170 2 out of 7 registries used, show all original rules.	27451
4. Check minimum number of events None	27451
5. Include endpoints None	27451
6. Filter based on genotype QC (FinnGen only)	27451

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4

NAME	M13_SCIATICA
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M54[3-4]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	7170
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M54[3-4]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	7170
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sciatica+with lumbago based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	175823	100824	74031
Only index persons	168115	97570	70545
Unadjusted period prevalence (%)
Whole population	2.53	2.89	2.07
Only index persons	3.21	3.59	2.69
Median age at first event (years)
Whole population	51.44	52.58	50.01
Only index persons	51.14	52.24	49.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27451	17393	10058
Unadjusted period prevalence (%)	5.38	5.93	4.43
Median age at first event (years)	52.91	51.84	54.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
24337: Matched controls
232872

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R52.2

ICD-10 Finland

Other chronic pain

7.5

323.0

1196

1604

M54.6

ICD-10 Finland

Pain in thoracic spine

5.6

323.0

1980

3612

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

323.0

2305

6790

R51.80

ICD-10 Finland

Headache

3.4

323.0

4407

14271

R06.0

ICD-10 Finland

Dyspnoea

2.4

323.0

6080

28039

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.0

323.0

6755

26350

A02BC02

ATC

pantoprazole; systemic

2.7

323.0

16788

105850

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

323.0

12360

87972

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

1105.1

323.0

342

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

323.0

382

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.0

323.0

2067

6918

SPAT1263

SPAT

Sampling

1.7

323.0

9604

63659

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

323.0

9750

60552

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

323.0

13210

92964

AA1AD

NOMESCO Finland

CT of head and brain

2.1

323.0

5234

27055

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

323.0

4818

22734

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

323.0

9658

47168

M01AC06

ATC

meloxicam; systemic, rectal

2.6

323.0

10049

50201

J01FA06

ATC

roxithromycin; oral

1.8

323.0

9653

61716

J01AA02

ATC

doxycycline; systemic

2.2

323.0

19043

145094

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

75.7

323.0

5043

801

J01DB01

ATC

cefalexin; oral

2.1

323.0

19744

155336

L08

ICPC

Shoulder symptom/complaint

2.3

323.0

4531

21410

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

323.0

7378

35045

M48.0

ICD-10 Finland

Spinal stenosis

108.7

323.0

5892

684

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

12454.2

323.0

1246

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

323.0

4131

16903

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.6

323.0

4252

17524

M01AB55

ATC

diclofenac, combinations; oral

3.5

323.0

1766

5115

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.5

323.0

1884

5501

L02

ICPC

Back symptom/complaint

3.4

323.0

2446

7347

R42

ICD-10 Finland

Dizziness and giddiness

2.3

323.0

5121

23817

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

323.0

4283

19435

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

27.8

323.0

538

189

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.1

323.0

2466

8053

R52.9

ICD-10 Finland

Pain, unspecified

3.0

323.0

2123

7141

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

323.0

6878

40167

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

304.4

323.0

342

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.1

323.0

2021

6621

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.5

323.0

1231

1642

G44.2

ICD-10 Finland

Tension-type headache

3.2

323.0

3821

12923

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.0

323.0

954

1349

R03AC02

ATC

salbutamol; inhalant

2.1

323.0

13004

82719

A01

ICPC

Pain general/multiple sites

3.9

323.0

2169

5742

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

243.0

323.0

375

N06AX16

ATC

venlafaxine; oral

3.0

323.0

4107

14727

N06AX21

ATC

duloxetine; oral

6.1

323.0

4383

8098

M03BC01

ATC

orphenadrine (citrate); systemic

4.1

323.0

8347

26048

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

8.9

323.0

4959

6483

H02AB06

ATC

prednisolone; systemic

2.2

323.0

11553

68302

L28

ICPC

Limited function/disability (L)

2.7

323.0

3633

14217

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

148.4

323.0

2960

217

NF1AA

NOMESCO Finland

Hip X-ray examination

3.1

323.0

2023

6678

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

323.0

2802

9100

M54.8

ICD-10 Finland

Other dorsalgia

6.5

323.0

1200

1837

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

323.0

16941

126929

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

323.0

951

R01AD09

ATC

mometasone; nasal

1.7

323.0

10478

71437

A02BA02

ATC

ranitidine; systemic

2.3

323.0

4633

21985

N06AX11

ATC

mirtazapine; oral

2.3

323.0

8267

42553

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

323.0

5643

29468

L86

ICPC

Back syndrome with radiating pain

12.6

323.0

2827

2410

L17

ICPC

Foot/toe symptom/complaint

2.2

323.0

6018

30430

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

98.1

323.0

1438

149

SPAT1301

SPAT

No procedures

1.9

323.0

7287

42463

N02AA05

ATC

oxycodone; systemic

3.3

323.0

3926

12676

SPAT1153

SPAT

Removal of sutures

2.0

323.0

7577

42436

N02AJ06

ATC

codeine and paracetamol; systemic

3.3

323.0

11259

48417

M54.3

ICD-10 Finland

Sciatica

64.5

323.0

7779

1681

A02BC03

ATC

lansoprazole; oral

2.6

323.0

7921

36365

N05BA04

ATC

oxazepam; oral

1.9

323.0

5730

31766

N05AH04

ATC

quetiapine; oral

2.2

323.0

3947

18811

N03AX16

ATC

pregabalin; oral

9.3

323.0

10850

18445

M01AB05

ATC

diclofenac; systemic, rectal

2.8

323.0

17782

113596

M70.6

ICD-10 Finland

Trochanteric bursitis

4.2

323.0

3897

10033

N02BE01

ATC

paracetamol; systemic, rectal

4.6

323.0

22198

161747

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

64.8

323.0

7030

1452

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.5

323.0

13902

64713

M25.5

ICD-10 Finland

Pain in joint

2.9

323.0

8231

35263

N02AX02

ATC

tramadol; systemic, rectal

6.0

323.0

15082

49451

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

19.6

323.0

886

449

M53.1

ICD-10 Finland

Cervicobrachial syndrome

5.0

323.0

3473

7543

M03BX02

ATC

tizanidine; oral

3.9

323.0

18180

100185

J01DA01

ATC

[U] cefalexin; systemic

1.8

323.0

14797

108871

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

119.5

323.0

597

UJF32

NOMESCO Finland

Coloscopy

2.3

323.0

6331

30870

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

323.0

9193

59430

M02AA07

ATC

piroxicam; topical

1.9

323.0

8487

50941

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

46.1

323.0

2402

551

M54.2

ICD-10 Finland

Cervicalgia

6.7

323.0

2192

3365

M01AX17

ATC

nimesulide; oral

2.5

323.0

6321

29082

M01AH01

ATC

celecoxib; oral (coxibs)

3.1

323.0

5139

18588

M54.1

ICD-10 Finland

Radiculopathy

28.1

323.0

1983

732

71700

ICD-8 Finland

+∞

323.0

569

M43.1

ICD-10 Finland

Spondylolisthesis

53.1

323.0

1639

316

M54.4

ICD-10 Finland

Lumbago with sciatica

111.3

323.0

19471

8068

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

323.0

5317

25306

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

323.0

3207

12496

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

323.0

10045

65694

S18

ICPC

Laceration/cut

2.0

323.0

9855

59395

M54.5

ICD-10 Finland

Low back pain

8.5

323.0

13348

28983

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

17.7

323.0

4737

3140

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

323.0

5864

25806

M01AE01

ATC

ibuprofen; systemic, rectal

2.6

323.0

21923

181650

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

17.7

323.0

726

403

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

240.3

323.0

1684

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

323.0

9536

60136

R53

ICD-10 Finland

Malaise and fatigue

2.1

323.0

4635

23415

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

226.7

323.0

2605

123

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.8

323.0

7832

33942

9211

FHL

Exploration or removal of diskusprolapse

494.3

323.0

607

WX110

NOMESCO Finland

Local anesthesy

1.8

323.0

16224

123145

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

323.0

5655

27216

M54.9

ICD-10 Finland

Dorsalgia, unspecified

9.9

323.0

4344

5003

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

323.0

4416

19424

N06AA09

ATC

amitriptyline; systemic

5.3

323.0

3543

7265

M43.0

ICD-10 Finland

Spondylolysis

98.9

323.0

634

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

1478.5

323.0

2231

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

79.4

323.0

646

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1045.0

323.0

946

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

670.9

323.0

946

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1073.9

323.0

867

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

323.0

7007

31113

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

132.2

323.0

10310

1288

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

18.8

323.0

1009

533

M79.1

ICD-10 Finland

Myalgia

2.8

323.0

3372

12560

M53.2

ICD-10 Finland

Spinal instabilities

117.2

323.0

362

L13

ICPC

Hip symptom/complaint

2.6

323.0

3765

15360

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

323.0

11598

78115

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

53.7

323.0

474

M79.6

ICD-10 Finland

Pain in limb

3.1

323.0

10507

45285

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

43.1

323.0

529

120

M01AE02

ATC

naproxen; oral, rectal

2.2

323.0

14314

91574

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

38.5

323.0

1630

433

M79.7

ICD-10 Finland

Fibromyalgia

7.1

323.0

1177

1653

N05CF01

ATC

zopiclone; oral

1.9

323.0

7429

42855

N03AX12

ATC

gabapentin; oral

11.9

323.0

8003

9200

A02BC05

ATC

esomeprazole; systemic

2.3

323.0

10531

57604

M01AH05

ATC

etoricoxib; oral

3.1

323.0

16479

94108

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.8

323.0

1192

2449

M01AH02

ATC

rofecoxib; oral

3.0

323.0

3416

12099

M47.9

ICD-10 Finland

Spondylosis, unspecified

55.7

323.0

1228

222

L03

ICPC

Low back symptom/complaint

5.4

323.0

9034

23010

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

16.0

323.0

790

488

M50.3

ICD-10 Finland

Other cervical disc degeneration

29.5

323.0

708

236

XA402

NOMESCO Finland

ENMG

7.9

323.0

914

1151

L01

ICPC

Neck symptom/complaint

2.7

323.0

3374

13118

M47.82

ICD-10 Finland

Other spondylosis, cervical region

34.5

323.0

1701

506

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

323.0

6139

35267

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

323.0

9660

52351

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

8.2

323.0

956

1149

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

15.1

323.0

2038

1403

P01AB01

ATC

metronidazole; oral, rectal

1.8

323.0

9404

60528

A02BC01

ATC

omeprazole; systemic

2.2

323.0

6682

34151

N05BA01

ATC

diazepam; systemic, rectal

2.4

323.0

3216

13994

M03BC51

ATC

orphenadrine, combinations; systemic

2.6

323.0

7920

36901

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.0

323.0

3715

13097

M54

ICD-10 Finland

Dorsalgia

3.8

323.0

3459

9841

TAB20

NOMESCO Finland

Epidural puncture

26.9

322.1

458

166

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

320.9

4469

22773

C07AB07

ATC

bisoprolol; oral

1.7

319.4

9891

66480

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

319.1

6882

41279

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

52.8

319.0

391

G54.0

ICD-10 Finland

Brachial plexus disorders

7.6

318.9

790

1025

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

318.2

2990

12678

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

315.7

4283

21569

M45

ICD-10 Finland

Ankylosing spondylitis

41.1

313.0

402

WZA90

NOMESCO Finland

Other doctors statement

1.9

311.3

5351

29576

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.3

309.5

1719

5248

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.9

306.4

1067

2141

ZXA00

NOMESCO Finland

Right side

1.9

305.4

6021

34919

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

108.6

302.3

336

N02AC04

ATC

dextropropoxyphene; oral

5.5

302.2

949

1693

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

300.8

2243

8335

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

300.7

293

R52.1

ICD-10 Finland

Chronic intractable pain

23.6

300.1

443

183

R4110

NOMESCO Finland

Physiotherapy

1.9

298.5

5982

34840

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

295.1

1587

4723

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

295.1

2107

7621

ZXA05

NOMESCO Finland

Left side

1.9

294.9

5642

32308

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

294.7

3765

18418

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

293.5

286

SPAT1310

SPAT

Counselling related to known health issue

1.8

293.4

7145

44323

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

26.0

292.9

420

157

J01FA10

ATC

azithromycin; systemic

1.6

291.7

13324

98889

M01AB08

ATC

etodolac; oral

2.9

289.0

1945

6772

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

288.8

3570

17202

L15

ICPC

Knee symptom/complaint

2.0

287.5

4613

24735

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

287.2

14710

112357

N06AB04

ATC

citalopram; systemic

1.9

287.1

4942

27206

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

286.9

2665

11192

J01MA02

ATC

ciprofloxacin; systemic

1.7

286.2

8416

55180

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.5

284.3

2423

9710

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

284.0

13281

98857

R07.3

ICD-10 Finland

Other chest pain

2.7

283.9

2184

8254

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

13.7

283.5

510

364

R06AE07

ATC

cetirizine; oral

1.7

282.8

9954

68609

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

281.9

6251

37526

J01CA04

ATC

amoxicillin; systemic

1.7

280.7

18691

153036

K02.1

ICD-10 Finland

Caries of dentine

1.6

279.4

13005

96489

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.0

278.1

1748

5812

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

274.9

1749

5861

J02AC01

ATC

fluconazole; systemic

1.7

274.5

9304

63294

J01FF01

ATC

clindamycin; systemic

1.8

273.3

6153

37053

L84

ICPC

Back syndrome without radiat pain

4.1

271.9

1137

2736

G47.3

ICD-10 Finland

Sleep apnoea

1.9

271.7

4760

26299

N03AE01

ATC

clonazepam; systemic

3.3

271.7

1486

4472

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

270.6

1658

5414

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

42.0

267.5

342

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.4

264.5

1375

3978

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

264.1

3657

18427

R03DC03

ATC

montelukast; oral

2.0

262.5

3713

18867

R05

ICPC

Cough

1.9

262.4

4931

27886

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

426.7

261.5

266

R5599

NOMESCO Finland

Other rehabilitation service

6.0

260.8

768

1264

SPAT1260

SPAT

Consultation of another employee

2.0

259.4

4014

21122

K30

ICD-10 Finland

Functional dyspepsia

2.4

259.2

2461

10418

R02

ICPC

Shortness of breath/dyspnoea

2.3

258.6

2625

11493

M01AX05

ATC

glucosamine; oral

2.0

258.1

4104

21821

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

256.3

3864

20121

A06AD11

ATC

lactulose; oral

2.2

254.8

2897

13381

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

254.0

11448

83360

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

253.4

7173

46102

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

253.3

4229

22881

J01FA09

ATC

clarithromycin; systemic

1.7

249.7

7198

46459

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

1192.7

249.0

247

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.2

247.3

2813

12981

L12

ICPC

Hand/finger symptom/complaint

2.1

245.3

3147

15314

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

245.0

2508

11009

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

242.3

3187

15666

Z50.1

ICD-10 Finland

Other physical therapy

3.2

238.9

1343

4115

M01AX01

ATC

nabumetone; oral

3.7

238.7

1117

2963

SPAT1312

SPAT

General health counselling

1.7

238.4

6984

45156

G43.9

ICD-10 Finland

Migraine, unspecified

3.1

238.2

1444

4666

N06AA10

ATC

nortriptyline; systemic

6.1

236.4

680

1085

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

235.1

2471

10972

N06AB10

ATC

escitalopram; oral

1.8

234.6

4504

25525

SPAT1216

SPAT

Assessment of functional ability

2.1

233.7

3081

15143

N01

ICPC

Headache

2.4

232.6

2219

9388

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

9.9

232.1

489

483

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

214.3

232.0

244

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

231.3

9177

64181

N05CF02

ATC

zolpidem; oral

1.9

229.4

4044

22224

M77.1

ICD-10 Finland

Lateral epicondylitis

2.6

228.9

1807

6896

N04BC05

ATC

pramipexole; oral

2.8

228.2

1644

5942

ACC51

NOMESCO Finland

Release of median nerve

2.7

228.0

1745

6542

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

227.5

2253

9708

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

227.1

1423

4701

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.4

223.9

1178

3431

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.9

223.8

663

1098

N02AJ13

ATC

tramadol and paracetamol; systemic

6.8

223.3

597

863

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

164.9

223.2

239

N03AX09

ATC

lamotrigine; oral

3.2

221.4

1248

3826

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

221.0

9859

70713

WX290

NOMESCO Finland

Other blockade of nerve

1.6

219.5

9871

70899

M02AA10

ATC

ketoprofen; topical

1.9

218.9

3473

18329

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

218.7

2238

9789

X58

ICD-10 Finland

Exposure to other specified factors

2.0

218.1

3022

15127

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.4

217.7

697

1268

C07AA05

ATC

propranolol; systemic

1.8

217.7

4348

24889

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

216.4

211

SPAT1240

SPAT

Therapeutic discussion

2.2

213.5

2426

11142

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

213.1

1887

7665

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

212.6

5652

35313

M01AH03

ATC

valdecoxib; oral

2.8

211.8

1527

5513

WX308

NOMESCO Finland

Sacral anesthesy

124.5

211.7

232

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

211.2

6602

43142

R05

ICD-10 Finland

Cough

1.8

210.9

4102

23242

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

210.1

11688

87884

D01

ICPC

Abdominal pain/cramps general

2.2

210.1

2323

10532

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

209.2

204

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.7

209.1

1549

5685

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.2

207.8

2342

10708

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

207.3

1221

3859

R03AC03

ATC

terbutaline; inhalant

2.0

206.6

3158

16402

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.0

206.1

1325

4446

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

205.8

1941

8141

KMAK

NOMESCO Finland

1.5

205.4

11776

88962

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.1

205.1

2538

12095

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.0

204.5

1303

4345

R05FB02

ATC

cough suppressants and expectorants

1.6

204.2

8162

56679

Z71.8

ICD-10 Finland

Other specified counselling

1.7

203.8

5090

31164

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

203.6

8480

59463

R03BA01

ATC

beclometasone; inhalant

2.0

202.9

3097

16066

R60.0

ICD-10 Finland

Localized oedema

2.2

202.7

2299

10536

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.8

201.9

603

1008

EBA00

NOMESCO Finland

Extraction of tooth

1.6

201.9

7050

47297

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

201.9

8756

61959

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.0

201.5

692

1362

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

201.3

1352

4667

C03CA01

ATC

furosemide; systemic

1.7

201.2

5033

30814

S06.0

ICD-10 Finland

Concussion

2.2

200.7

2212

10003

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

199.8

1877

7851

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

199.3

8379

58806

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

199.2

1458

5309

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

198.7

2112

9386

M35.7

ICD-10 Finland

Hypermobility syndrome

9.0

198.2

440

477

B01AB05

ATC

enoxaparin; parenteral

1.6

197.0

6278

41076

N06AB03

ATC

fluoxetine; oral

2.0

196.9

2833

14348

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.8

195.3

1369

4852

UKC02

NOMESCO Finland

Cystoscopy

2.0

194.6

3025

15782

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

194.4

2874

14708

R96

ICPC

Asthma

2.3

193.8

1895

8085

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

6.0

193.8

567

924

SPAT1229

SPAT

Assessment of need for aid

2.5

192.5

1626

6425

SPAT1254

SPAT

Administration of medicine

2.0

192.2

2915

15058

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

192.0

4588

27649

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.3

191.5

1944

8443

H01

ICPC

Ear pain/earache

2.1

191.1

2285

10708

G83.4

ICD-10 Finland

Cauda equina syndrome

50.4

190.6

235

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

20.3

189.3

292

139

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

189.1

2169

9975

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

458.5

188.3

191

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.4

187.1

594

1069

R21

ICPC

Throat symptom/complaint

1.8

187.1

4113

24137

R03BA02

ATC

budesonide; inhalant

1.8

186.7

3739

21297

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

27.3

186.3

263

H02AB04

ATC

methylprednisolone; systemic

1.9

185.3

3103

16614

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

184.9

4191

24817

M41.9

ICD-10 Finland

Scoliosis, unspecified

16.8

184.8

305

176

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

184.6

4019

23505

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

184.2

8733

62686

R06AX27

ATC

desloratadine; oral

1.6

183.1

5869

38317

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

42.4

182.9

233

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

182.8

5832

38030

J01EA01

ATC

trimethoprim; systemic

1.6

182.2

5244

33261

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

181.9

1257

4412

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.7

181.1

1313

4746

L16

ICPC

Ankle symptom/complaint

2.2

181.1

2090

9629

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

180.1

1725

7272

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.8

179.5

808

2067

A03FA02

ATC

cisapride; oral, rectal

2.4

179.4

1614

6586

L29

ICPC

Musculoskeletal sympt/complt other

2.4

178.9

1608

6559

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.3

178.7

1750

7457

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

178.2

1812

7868

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.9

178.1

777

1934

R74

ICPC

Upper respiratory infection acute

1.6

176.8

5966

39403

L14

ICPC

Leg/thigh symptom/complaint

2.4

174.4

1565

6377

R13

ICD-10 Finland

Dysphagia

2.6

174.3

1367

5171

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

173.8

4194

25253

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

173.5

2659

13754

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

173.2

1675

7092

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

173.2

2318

11367

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

7.3

172.8

437

583

P03

ICPC

Feeling depressed

2.2

172.2

1900

8567

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

21.8

171.7

259

115

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.9

170.8

1156

4000

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

169.3

7012

48561

A02BA04

ATC

nizatidine; systemic

2.3

168.8

1635

6924

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

168.5

2800

14911

R03BA05

ATC

fluticasone; inhalant

1.7

166.4

3761

22173

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

166.2

2157

10436

C10AA07

ATC

rosuvastatin; oral

1.6

166.1

4798

30346

N30.0

ICD-10 Finland

Acute cystitis

1.9

166.0

2794

14939

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.3

165.9

895

2648

Z01.2

ICD-10 Finland

Dental examination

1.5

165.7

8754

63905

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

164.8

1490

6091

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

164.0

160

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.2

163.9

949

2955

M76.6

ICD-10 Finland

Achilles tendinitis

3.4

163.4

850

2446

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

163.2

2707

14392

R01AD12

ATC

fluticasone furoate; nasal

1.5

162.6

6347

43261

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

162.5

1855

8485

D11

ICPC

Diarrhoea

2.0

162.4

2322

11673

M76.0

ICD-10 Finland

Gluteal tendinitis

7.1

161.8

417

572

J45

ICD-10 Finland

Asthma

2.1

161.7

2088

10075

A02BC04

ATC

rabeprazole; oral

2.2

161.2

1855

8514

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

161.0

5324

34831

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

160.9

157

C01DA14

ATC

isosorbide mononitrate; oral

2.0

160.4

2446

12603

N05CD07

ATC

temazepam; oral

2.0

160.3

2404

12307

M48.9

ICD-10 Finland

Spondylopathy, unspecified

107.2

160.2

178

R01AD08

ATC

fluticasone; nasal

1.6

160.1

6067

41035

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.2

160.0

527

989

K07.60

ICD-10 Finland

Snapping jaw

2.8

159.6

1124

3983

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

10.3

159.3

326

305

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

158.7

2333

11853

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

158.4

3334

19194

SPAT1283

SPAT

Restricted health certificate

1.7

158.1

3693

21950

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

158.0

2683

14372

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

157.0

1041

3552

M01AC01

ATC

piroxicam; systemic, rectal

1.9

156.9

2757

14946

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

156.6

2356

12069

D06

ICPC

Abdominal pain localized other

2.2

156.1

1713

7690

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

197.4

155.3

164

E66.8

ICD-10 Finland

Other obesity

2.6

155.1

1244

4760

N06AB06

ATC

sertraline; oral

2.0

154.7

2328

11925

R51

ICD-10 Finland

Headache

2.7

154.5

1156

4249

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

154.1

2815

15460

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

153.8

1553

6701

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.6

153.8

1253

4837

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.7

153.8

1169

4335

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

153.5

3577

21228

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

153.0

5376

35632

SFA00

NOMESCO Finland

Small filling

1.8

152.8

2800

15391

C10AA05

ATC

atorvastatin; oral

1.5

152.7

7324

52125

J20

ICD-10 Finland

Acute bronchitis

2.1

152.4

2000

9701

A04

ICPC

Weakness/tiredness general

1.9

151.5

2479

13093

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.8

151.4

1039

3623

SPAT1058

SPAT

PEF monitoring instruction

2.2

151.0

1712

7798

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

150.7

147

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

150.7

2685

14613

C07AB02

ATC

metoprolol; systemic

1.7

150.1

3795

23046

S29

ICPC

Skin symptom/complaint other

1.7

149.9

3336

19508

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

47.2

149.2

186

R09

ICPC

Sinus symptom/complaint

2.2

148.7

1659

7498

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

147.7

2111

10593

J01CA08

ATC

pivmecillinam; oral

1.5

147.6

8393

61768

R35

ICD-10 Finland

Polyuria

2.5

147.6

1238

4853

J46

ICD-10 Finland

Status asthmaticus

3.8

147.5

671

1730

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

147.4

1583

7030

R11

ICD-10 Finland

Nausea and vomiting

2.2

146.9

1594

7111

ICD-10 Finland

4.0

146.6

628

1536

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

146.2

1792

8441

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

146.1

1544

6803

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

146.1

2950

16724

R03BB04

ATC

tiotropium bromide; inhalant

2.1

145.3

1825

8688

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

144.9

1740

8124

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

8.5

144.4

331

379

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

144.3

1126

4238

N06AX03

ATC

mianserin; oral

2.7

144.2

1082

3979

A28

ICPC

Limited function/disability NOS

1.9

143.4

2538

13763

A11

ICPC

Chest pain NOS

2.3

143.2

1499

6575

M70.7

ICD-10 Finland

Other bursitis of hip

4.1

143.1

601

1444

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

142.7

3118

18105

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

142.6

1403

5973

Z00.0

ICD-10 Finland

General medical examination

1.7

142.4

3656

22262

C08CA01

ATC

amlodipine; oral

1.5

141.9

6715

47478

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

141.7

1627

7443

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

141.5

822

2563

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

7.6

140.9

345

439

G04CA02

ATC

tamsulosin; oral

1.7

140.5

3531

21365

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

139.9

4055

25507

D07AC01

ATC

betamethasone; topical

1.5

139.9

6970

49784

R55

ICD-10 Finland

Syncope and collapse

2.0

139.7

2025

10205

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

139.2

2128

10942

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

139.1

1018

3688

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.8

138.8

968

3405

H02AB07

ATC

prednisone; oral

1.8

138.8

2851

16230

P76

ICPC

Depressive disorder

2.3

138.3

1327

5576

S80.0

ICD-10 Finland

Contusion of knee

2.3

137.4

1383

5950

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

137.2

3416

20599

K59.0

ICD-10 Finland

Constipation

2.6

137.1

1093

4164

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.2

137.0

1580

7240

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

136.7

665

1813

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

136.5

3368

20255

C10AA01

ATC

simvastatin; oral

1.4

136.1

8026

59230

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

440.6

135.9

138

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

134.6

1405

6148

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

134.6

1906

9511

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

134.5

2491

13701

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

134.1

932

3271

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

133.9

1338

5733

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

133.2

130

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

133.1

5667

39051

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

133.1

5158

34801

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

25.0

133.0

192

M01AE52

ATC

naproxen and esomeprazole; oral

3.1

132.8

781

2456

P01

ICPC

Feeling anxious/nervous/tense

2.0

132.7

1966

9980

N17

ICPC

Vertigo/dizziness

1.9

132.6

2063

10669

N03AF01

ATC

carbamazepine; oral, rectal

2.5

132.3

1098

4275

U02

ICPC

Urinary frequency/urgency

1.8

132.3

2541

14141

NA3BG

SPAT

4.5

132.2

500

1087

A01AB09

ATC

miconazole; local oral

2.0

132.0

1766

8612

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

132.0

1480

6693

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

131.9

2027

10434

SPAT1097

SPAT

Recording of ECG

1.7

131.6

2831

16331

XKD00

NOMESCO Finland

Uroflowmetry

1.8

131.1

2655

15026

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.0

130.4

806

2623

N06AA12

ATC

doxepin; systemic

2.5

130.2

1126

4482

D19

ICPC

Teeth/gum symptom/complaint

1.5

130.2

5396

36931

-1

NOMESCO Finland

1.5

130.0

6892

49682

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

129.9

1620

7673

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

129.9

1854

9277

M77.4

ICD-10 Finland

Metatarsalgia

2.4

129.4

1169

4761

C10AX09

ATC

ezetimibe; oral

1.9

129.4

2079

10874

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

129.2

1652

7908

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.8

129.0

587

1514

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

128.9

15275

127355

P01BA02

ATC

hydroxychloroquine; oral

2.0

127.7

1679

8124

M01AB51

ATC

indometacin, combinations; oral, rectal

4.0

127.2

546

1338

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

127.1

1198

4984

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

126.7

2010

10460

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

126.5

985

3699

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.0

126.3

768

2469

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

126.1

2399

13294

C09CA06

ATC

candesartan; oral

1.6

126.1

4320

28259

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

35.5

125.8

166

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

125.4

1229

5214

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

125.4

4219

27475

B01AC04

ATC

clopidogrel; oral

1.7

124.8

2653

15230

P06

ICPC

Sleep disturbance

1.9

124.3

1971

10250

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.5

123.7

607

1666

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

123.7

1455

6717

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

123.6

5144

35167

S22.3

ICD-10 Finland

Fracture of rib

2.3

123.6

1248

5370

K08.80

ICD-10 Finland

Toothache NOS

2.0

123.4

1679

8237

WX002

NOMESCO Finland

Sedation and analgesia

1.6

122.1

3850

24650

R52.0

ICD-10 Finland

Acute pain

3.2

121.9

691

2117

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

31.8

121.8

165

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.2

121.8

1402

6410

J05AB01

ATC

aciclovir; systemic

1.6

121.8

4249

27885

ZXA10

NOMESCO Finland

Bilateral

1.6

121.6

3567

22417

N06AX12

ATC

bupropion; oral

2.2

121.5

1281

5626

M03BX01

ATC

baclofen; systemic

4.8

121.5

426

857

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

1152.7

120.9

120

ZZH40

NOMESCO Finland

Substitute of bone

8.9

120.1

266

288

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

119.6

2572

14799

TAC99

NOMESCO Finland

Other blockade for chronic pain

10.7

119.6

240

217

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.3

119.5

639

1875

A03

ICPC

Fever

1.7

119.5

3089

18759

A29

ICPC

General symptom/complaint other

1.8

119.2

2097

11307

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.7

119.1

850

3030

G57.1

ICD-10 Finland

Meralgia paraesthetica

5.3

118.9

384

705

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

22.4

118.8

177

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

118.7

1306

5849

G04BD12

ATC

mirabegron; oral

1.9

118.3

1805

9250

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.1

117.6

701

2223

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

117.5

1258

5564

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

117.5

1290

5772

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

117.5

2317

12973

J01MA14

ATC

moxifloxacin; systemic

1.9

117.3

1769

9026

SPAT1210

SPAT

Application of cast or individual aid

2.6

117.0

943

3608

SPAT1325

SPAT

Vaccination

1.4

116.6

6544

47480

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

115.6

1810

9360

R4120

NOMESCO Finland

Occupational therapy

2.2

115.5

1283

5768

E0000UV

ATC

1.4

115.5

7947

59855

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

115.4

2164

11915

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

115.1

3436

21662

I20.09

ICD-10 Finland

Unstable angina

2.5

115.1

993

3944

R06.5

ICD-10 Finland

Mouth breathing

1.9

115.1

1749

8944

M01AE51

ATC

ibuprofen, combinations; systemic

4.9

115.0

395

777

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

115.0

2300

12932

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

114.9

1521

7372

H02BX01

ATC

methylprednisolone, combinations; systemic

2.4

114.5

1015

4088

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

1085.1

113.8

113

R50.9

ICD-10 Finland

Fever, unspecified

1.7

113.8

2609

15290

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

113.4

762

2616

AN1

Coronary angiography

1.8

113.4

1996

10754

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

113.2

5613

39697

XQ800

NOMESCO Finland

Prick test

2.0

112.5

1553

7653

W19

ICD-10 Finland

Unspecified fall

1.9

112.2

1756

9075

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

111.9

1388

6547

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

108.4

111.9

124

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

111.9

4269

28533

R01AD01

ATC

beclometasone; nasal

1.6

111.8

3160

19626

L18

ICPC

Muscle pain

2.8

111.6

770

2689

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.1

111.2

1384

6534

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

5.3

111.1

357

652

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

110.6

2250

12708

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.7

110.3

830

3053

M89.0

ICD-10 Finland

Algoneurodystrophy

7.8

110.1

265

329

K04.0

ICD-10 Finland

Pulpitis

1.8

110.0

2020

11038

N06AX05

ATC

trazodone; oral

3.3

109.8

594

1758

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

109.5

1463

7111

R00.2

ICD-10 Finland

Palpitations

2.1

109.5

1407

6732

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

109.4

1546

7687

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

109.3

2571

15170

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

109.2

3990

26389

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.7

109.0

514

1366

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

34.0

108.9

145

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

108.9

8550

65698

WX704

NOMESCO Finland

Intubation

2.0

108.2

1417

6832

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

107.9

993

4075

C05AA08

ATC

fluocortolone; rectal, topical

1.6

107.7

2845

17339

A05

ICPC

Feeling ill

2.3

107.6

1095

4725

R03BA08

ATC

ciclesonide; inhalant

1.9

107.5

1663

8553

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

54.3

107.1

130

F34.1

ICD-10 Finland

Dysthymia

2.7

107.1

759

2694

L11

ICPC

Wrist symptom/complaint

2.0

106.9

1522

7584

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

106.8

1134

4992

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

156.5

106.3

114

JAH01

NOMESCO Finland

Laparoscopy

2.4

105.7

994

4125

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

105.6

4159

27950

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

+∞

105.5

103

M46.4

ICD-10 Finland

Discitis, unspecified

343.5

105.5

108

RF210

NOMESCO Finland

3.1

105.4

624

1968

R12

ICD-10 Finland

Heartburn

2.0

105.1

1389

6723

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

104.4

924

3716

R07.0

ICD-10 Finland

Pain in throat

2.1

103.9

1206

5524

D02

ICPC

Abdominal pain epigastric

2.2

103.9

1118

4948

N06AX26

ATC

vortioxetine; oral

2.2

103.5

1125

5002

R06AX22

ATC

ebastine; oral

1.6

103.3

3513

22811

R51.81

ICD-10 Finland

Facial pain NOS

3.5

103.0

504

1380

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

14.3

103.0

180

121

H57.1

ICD-10 Finland

Ocular pain

2.9

102.9

677

2292

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.8

102.8

463

1184

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

207.5

102.7

108

H03AA01

ATC

levothyroxine sodium; systemic

1.5

102.6

4681

32434

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

102.0

1443

7170

M01AB01

ATC

indometacin; systemic, rectal

2.0

101.5

1334

6439

M75.8

ICD-10 Finland

Other shoulder lesions

2.8

101.4

688

2376

N05BA12

ATC

alprazolam; oral

1.8

101.3

2012

11261

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

101.2

1085

4794

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.2

101.1

1155

5252

XX2CT

NOMESCO Finland

Other injection with CT guidance

118.5

101.1

111

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

100.8

5351

38200

A07AA02

ATC

nystatin; oral

2.1

100.7

1173

5379

M77.0

ICD-10 Finland

Medial epicondylitis

3.3

100.4

538

1581

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.4

100.4

275

412

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

100.2

2926

18285

T90

ICPC

Diabetes non-insulin dependent

1.5

100.1

4203

28596

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

100.1

4060

27421

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

100.1

1540

7896

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

99.8

1282

6127

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

99.6

6599

49047

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

99.5

815

3145

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

41.7

99.0

126

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

99.0

870

3485

T78.4

ICD-10 Finland

Allergy, unspecified

2.4

98.2

926

3845

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

98.2

2389

14204

J01MA12

ATC

levofloxacin; systemic

1.5

98.2

3362

21838

H92.0

ICD-10 Finland

Otalgia

2.3

97.9

997

4299

C09CA01

ATC

losartan; oral

1.5

97.7

4448

30768

R33

ICD-10 Finland

Retention of urine

2.1

97.4

1226

5810

M19.8

ICD-10 Finland

Other specified arthrosis

2.8

97.4

673

2352

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

97.1

2872

17994

XF402

NOMESCO Finland

ECG with work load test

1.8

97.0

1997

11295

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

96.7

1766

9615

J01

ICD-10 Finland

Acute sinusitis

2.3

96.7

1002

4357

R1250

NOMESCO Finland

Evaluation of functional capability

3.5

96.4

475

1308

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

17.9

96.0

154

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

95.8

2175

12670

R25.2

ICD-10 Finland

Cramp and spasm

3.6

95.6

462

1253

M50.8

ICD-10 Finland

Other cervical disc disorders

51.1

95.5

117

R15

ICD-10 Finland

Faecal incontinence

3.2

95.4

533

1615

SPAT1211

SPAT

Application of soft bandage

1.8

95.2

1662

8910

TAB00

NOMESCO Finland

Lumbar puncture

2.4

95.1

883

3639

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

94.7

2186

12794

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

94.5

1701

9212

N03AX11

ATC

topiramate; oral

3.1

94.3

560

1770

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.2

94.2

266

415

R03AC13

ATC

formoterol; inhalant

2.3

94.1

961

4149

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

93.7

1236

5971

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

93.7

705

2592

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

93.5

5374

38848

D82

ICPC

Teeth/gum disease

1.4

93.5

6945

52516

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.3

93.5

509

1514

L04

ICPC

Chest symptom/complaint

2.2

93.3

1072

4884

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

93.2

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

93.2

1335

6661

J01FA15

ATC

telithromycin; oral

1.7

93.1

2065

11941

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

92.2

1277

6285

N07BA03

ATC

varenicline; oral

2.1

92.1

1069

4892

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

91.8

1303

6476

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

91.3

2431

14801

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

91.0

1156

5496

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.2

90.9

1000

4469

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.1

90.9

372

874

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.9

90.5

602

2053

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

25.8

90.5

129

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

10.6

90.5

182

166

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.9

90.3

589

1984

M15

ICD-10 Finland

Polyarthrosis

2.3

90.3

857

3570

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.8

90.2

1760

9780

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

89.9

919

3966

M47.8

ICD-10 Finland

Other spondylosis

60.4

89.8

107

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.0

89.7

1171

5629

M25.2

ICD-10 Finland

Flail joint

4.9

89.7

311

619

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.6

89.5

704

2655

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

89.3

2142

12665

A46

ICD-10 Finland

Erysipelas

1.6

89.3

2432

14891

L05

ICPC

Flank/axilla symptom/complaint

2.2

89.3

993

4458

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

6.0

89.0

257

413

C08CA13

ATC

lercanidipine; oral

1.6

88.8

2306

13937

SPAT1202

SPAT

Intra-articular injection

2.7

88.8

632

2247

S21

ICPC

Skin texture symptom/complaint

1.6

88.1

2253

13558

UJH02

NOMESCO Finland

Anoscopy

2.3

87.8

863

3656

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

87.8

3475

23268

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.1

87.1

513

1613

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.7

87.1

409

1084

U01

ICPC

Dysuria/painful urination

1.9

87.0

1350

6936

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

86.9

780

3156

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

4.6

86.8

314

654

M75.2

ICD-10 Finland

Bicipital tendinitis

3.1

86.8

499

1544

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

176.7

86.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

86.6

4445

31380

XKC03

NOMESCO Finland

Water cystometry

2.8

86.6

605

2128

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

86.2

947

4226

7244A

ICD-9 Finland

Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified

+∞

86.1

A02BX02

ATC

sucralfate; oral

2.4

85.8

753

3013

UJD02

NOMESCO Finland

Gastroscopy

2.3

85.8

881

3811

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

85.7

829

3483

SPAT1285

SPAT

Provision of consultation response

2.1

85.7

1022

4730

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

85.6

1124

5415

D07AD01

ATC

clobetasol; topical

1.5

85.5

2971

19306

L09

ICPC

Arm symptom/complaint

2.4

85.4

805

3340

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

13.8

85.3

151

105

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

7.4

85.3

211

274

N39.3

ICD-10 Finland

Stress incontinence

1.9

85.2

1376

7169

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

85.1

1545

8379

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

85.1

1332

6862

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

85.0

677

2570

A98

ICPC

Health maint/preventive medicine

1.7

84.9

22826

209777

A10BA02

ATC

metformin; oral

1.4

84.8

4979

36023

C01CA24

ATC

epinephrine; parenteral

2.0

84.6

1198

5945

S20.2

ICD-10 Finland

Contusion of thorax

2.2

84.5

897

3940

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

84.5

1156

5660

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.3

84.4

460

1369

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.0

84.1

527

1728

SPAT1106

SPAT

Acupuncture

7.2

84.0

213

287

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

83.9

3327

22266

K04.08

ICD-10 Finland

Other specified pulpit

1.9

83.7

1270

6469

G04BD08

ATC

solifenacin; oral

2.0

83.6

1139

5564

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

83.6

7464

57868

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.5

83.4

705

2764

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.0

83.3

1160

5721

WX402

NOMESCO Finland

General anaesthesia

1.5

83.1

3182

21128

N06AX22

ATC

agomelatine; oral

3.2

82.7

470

1442

M53.9

ICD-10 Finland

Dorsopathy, unspecified

11.0

82.2

162

142

SPAT1360

SPAT

Extensive global examination

1.9

82.2

1366

7185

R29

ICPC

Respiratory symptom/complaint other

2.0

82.0

1171

5829

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

81.9

938

4262

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

81.8

3127

20746

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

81.8

2224

13589

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

81.8

3691

25368

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

81.5

662

2541

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

81.4

1378

7297

S70.0

ICD-10 Finland

Contusion of hip

2.6

81.1

621

2307

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

80.4

10103

82155

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

80.3

2002

11951

SPAT1252

SPAT

Overall medication plan or its review

1.9

80.2

1193

6031

M23.8

ICD-10 Finland

Other internal derangements of knee

2.4

79.7

730

2984

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.4

79.5

744

3076

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.9

79.5

517

1739

J01DA06

ATC

[U] cefuroxime; systemic

1.5

79.4

2821

18406

G50.1

ICD-10 Finland

Atypical facial pain

3.6

79.3

380

1024

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.9

79.3

273

540

S01

ICPC

Pain/tenderness of skin

2.3

79.1

788

3361

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

79.0

874

3911

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.0

79.0

1107

5468

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.5

78.9

662

2586

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

78.8

1042

5029

R10.0

ICD-10 Finland

Acute abdomen

2.6

78.8

614

2303

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

78.8

1012

4830

M22.4

ICD-10 Finland

Chondromalacia patellae

2.5

78.8

644

2481

M75.5

ICD-10 Finland

Bursitis of shoulder

3.1

78.7

449

1381

C10AA04

ATC

fluvastatin; oral

1.8

78.5

1420

7690

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.1

78.4

948

4410

L60.0

ICD-10 Finland

Ingrowing nail

2.3

78.0

791

3401

7225A

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]

+∞

77.9

R30.0

ICD-10 Finland

Dysuria

2.5

77.8

670

2653

R03AC12

ATC

salmeterol; inhalant

2.3

77.8

787

3381

R06AX13

ATC

loratadine; oral

1.5

77.8

2980

19764

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

77.7

1091

5392

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

77.4

4419

31731

Z00.8

ICD-10 Finland

Other general examinations

1.9

77.4

1306

6905

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

77.2

382

1057

H29

ICPC

Ear symptom/complaint other

1.7

76.6

1763

10281

J45.8

ICD-10 Finland

Mixed asthma

2.7

76.4

571

2091

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

76.3

4346

31183

SPAT1104

SPAT

Monitoring of emergency patient

1.9

76.2

1198

6178

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

35.6

76.1

100

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.7

75.8

347

901

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.7

75.8

555

2009

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.0

75.7

457

1463

A99

ICPC

Disease/condition unspecnature/site

1.8

75.6

1404

7665

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

75.5

1006

4872

J01FA01

ATC

erythromycin; systemic

1.5

75.2

2704

17670

1220

FHL

Arthroscopy

2.3

75.2

750

3198

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.5

75.1

614

2365

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.8

74.8

1404

7688

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

74.8

585

2198

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.2

74.7

423

1295

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

74.7

1711

9962

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

74.6

1649

9501

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

74.6

1932

11642

J01MA06

ATC

norfloxacin; oral

1.5

74.4

2530

16321

K85

ICPC

Elevated blood pressure

1.5

74.3

2572

16662

H13

ICPC

Plugged feeling ear

1.5

74.2

3081

20773

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

74.0

1875

11225

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

74.0

1005

4901

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

73.9

2441

15635

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

73.8

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

73.8

1070

5353

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.8

73.6

509

1779

C08DA01

ATC

verapamil; systemic

2.3

73.5

721

3051

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

73.4

2636

17218

M41.8

ICD-10 Finland

Other forms of scoliosis

17.1

73.2

119

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

73.1

772

3380

M53.8

ICD-10 Finland

Other specified dorsopathies

9.0

73.1

160

171

R01AD11

ATC

triamcinolone; nasal

1.7

73.0

1703

9964

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

72.5

1703

9985

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.1

72.5

899

4226

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

72.2

3805

26880

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

72.1

988

4834

U05

ICPC

Urination problems other

2.2

72.0

767

3373

N06AB05

ATC

paroxetine; oral

1.9

71.8

1191

6255

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

71.7

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

+∞

71.7

K80

ICPC

Cardiac arrhythmia NOS

1.8

71.3

1288

6964

NF1DA

NOMESCO Finland

X-ray of hips

3.2

71.2

400

1218

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

71.2

1276

6880

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

3.0

71.1

428

1366

ACC53

NOMESCO Finland

Release of ulnar nerve

3.9

71.0

305

750

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

70.9

996

4920

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

679.9

70.9

205

Kela drug reimbursment

Chronic hypertension

1.4

70.9

4608

33771

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

179.9

70.8

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

70.7

405

1250

C10AC01

ATC

colestyramine; oral

2.7

70.7

507

1810

D10

ICPC

Vomiting

2.0

70.7

1015

5058

7233A

ICD-9 Finland

Other disorders of cervical region, Cervicobrachial syndrome (diffuse)

+∞

70.7

D12

ICPC

Constipation

2.5

70.4

569

2179

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.0

70.3

296

715

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

20.6

70.3

107

L88

ICPC

Rheumatoid/seropositive arthritis

2.3

70.2

665

2766

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

70.2

995

4935

U07

ICPC

Urine symptom/complaint other

2.0

70.1

989

4895

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.4

70.0

356

1007

N05AA02

ATC

levomepromazine; systemic

2.1

69.9

806

3674

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.1

69.8

817

3746

NG1DA

NOMESCO Finland

X-ray of knees

3.4

69.7

354

1000

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

69.7

800

3639

G43.3

ICD-10 Finland

Complicated migraine

3.5

69.7

339

926

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

69.6

672

2821

H02.3

ICD-10 Finland

Blepharochalasis

1.9

69.6

1075

5506

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

43.9

69.3

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.1

69.1

398

1234

C08CA05

ATC

nifedipine; systemic

1.9

69.0

1078

5541

L20

ICPC

Joint symptom/complaint NOS

2.4

68.6

642

2653

L92

ICPC

Shoulder syndrome

2.9

68.3

447

1511

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

68.2

2739

18306

S15

ICPC

Foreign body in skin

1.9

68.2

1095

5687

TAC00

NOMESCO Finland

Peripheral nerve block

10.0

68.1

140

134

SPAT1255

SPAT

Intravenous administration of medicine

1.8

67.8

1155

6119

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

140.1

67.7

R4110

SPAT

2.6

67.6

519

1930

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

67.5

6115

47154

M65.3

ICD-10 Finland

Trigger finger

2.1

67.4

793

3645

D09

ICPC

Nausea

2.2

67.3

719

3166

M51

ICD-10 Finland

Other intervertebral disc disorders

9.8

67.3

140

137

T82

ICPC

Obesity

2.2

67.0

714

3141

R75

ICPC

Sinusitis acute/chronic

2.1

67.0

836

3942

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

66.9

875

4204

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.7

66.9

476

1693

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.3

66.7

660

2802

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

66.6

817

3820

RF420

NOMESCO Finland

3.9

66.6

291

727

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.4

66.5

345

991

M48

ICD-10 Finland

Other spondylopathies

30.9

66.4

SPAT1262

SPAT

Handing over of treatment supplies

1.4

66.3

3214

22305

M41.2

ICD-10 Finland

Other idiopathic scoliosis

54.8

66.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.7

66.2

476

1702

A02BA03

ATC

famotidine; systemic

2.3

66.2

659

2809

M09AX01

ATC

hyaluronic acid; parenteral

2.1

65.8

809

3788

R06.2

ICD-10 Finland

Wheezing

2.1

65.8

777

3578

NBG10

NOMESCO Finland

Acromioplastia

2.8

65.8

457

1602

G56.4

ICD-10 Finland

Causalgia

9.4

65.7

140

143

N62

ICD-10 Finland

Hypertrophy of breast

2.1

65.7

780

3598

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

65.7

1005

5127

L83

ICPC

Neck syndrome

6.5

65.6

178

265

72898

ICD-8 Finland

Vertebrogenic pain syndrome, Alia definita

+∞

65.6

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

65.4

1334

7492

G04BD07

ATC

tolterodine; oral

2.0

65.3

832

3952

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

65.3

937

4664

D07AA02

ATC

hydrocortisone; topical

1.5

65.3

2459

16201

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.2

65.2

671

2903

RF120

NOMESCO Finland

4.3

65.2

251

558

R06AE09

ATC

levocetirizine; oral

1.5

65.1

2718

18303

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.7

65.0

1427

8197

N03AG01

ATC

valproic acid; systemic, rectal

1.8

65.0

1119

5949

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

10.4

64.9

131

121

L99

ICPC

Musculoskeletal disease other

3.1

64.9

371

1143

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

64.9

959

4829

E000001

ATC

1.4

64.8

3785

27176

P29

ICPC

Psychological sympt/compl other

1.9

64.8

1012

5200

A01AB04

ATC

amphotericin B; local oral

2.0

64.8

828

3938

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.8

64.7

451

1584

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

64.7

686

3011

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

27.9

64.7

35399

ICD-8 Finland

Sciatica

6.6

64.7

172

249

G03DB01

ATC

dydrogesterone; oral

1.5

64.6

2558

17037

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.2

64.5

352

1051

R06.4

ICD-10 Finland

Hyperventilation

3.3

64.5

344

1010

P74

ICPC

Anxiety disorder/anxiety state

2.3

64.5

655

2817

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

64.4

1271

7066

R07

ICPC

Sneezing/nasal congestion

1.8

64.4

1138

6104

M48.8

ICD-10 Finland

Other specified spondylopathies

43.2

64.4

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.5

64.3

198

346

OAA65

SPAT

1.6

64.3

1764

10774

F29

ICPC

Eye symptom/complaint other

1.7

64.3

1425

8206

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.6

64.2

306

823

SPAT1284

SPAT

Extensive health certificate

2.5

64.2

538

2101

Angiography of the heart and coronary arteries

2.0

64.1

907

4493

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

64.1

1840

11368

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

64.1

4771

35664

B02AA02

ATC

tranexamic acid; systemic

1.5

63.9

2844

19401

L04AA13

ATC

leflunomide; oral

2.7

63.8

471

1713

F01

ICPC

Eye pain

2.5

63.8

510

1942

A06AC51

ATC

ispaghula, combinations; systemic

2.0

63.3

886

4373

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

63.2

644

2775

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

63.1

1460

8513

L10

ICPC

Elbow symptom/complaint

2.0

63.0

828

3985

C10AA03

ATC

pravastatin; oral

1.8

63.0

1128

6078

N06AA06

ATC

trimipramine; systemic

2.6

62.9

497

1880

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.6

62.6

1562

9296

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

62.6

605

2543

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

12.1

62.5

117

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

62.4

1483

8711

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

62.2

1020

5333

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.5

62.2

520

2029

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

62.2

510

1969

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.4

62.2

560

2272

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

61.8

500

1916

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

61.7

504

1942

N06AG02

ATC

moclobemide; oral

2.0

61.7

822

3979

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

13.4

61.5

110

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

61.3

1046

5545

D07AC13

ATC

mometasone; topical

1.3

61.1

5510

42343

N81.6

ICD-10 Finland

Rectocele

1.8

61.1

1133

6173

SPAT1101

SPAT

Orthostatic test

2.1

60.8

709

3244

B01AF01

ATC

rivaroxaban; oral

1.6

60.8

1900

11982

Z30.2

ICD-10 Finland

Sterilization

1.5

60.8

2026

12972

F32

ICD-10 Finland

Depressive episode

1.9

60.7

946

4855

H93.1

ICD-10 Finland

Tinnitus

1.8

60.6

1156

6353

Z08

ICPC

Social welfare problem

3.9

60.5

262

650

S97

ICPC

Chronic ulcer skin

2.0

60.2

851

4213

P20

ICPC

Memory disturbance

1.6

60.2

1695

10415

N07BC02

ATC

methadone; systemic

12.2

60.2

112

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.1

60.2

737

3445

N76.0

ICD-10 Finland

Acute vaginitis

1.9

60.0

960

4974

K04.09

ICD-10 Finland

Pulpit UNS

2.0

59.9

776

3712

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.6

59.9

283

756

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.3

59.9

602

2576

XF404

NOMESCO Finland

Ambulatory ECG

1.6

59.8

1546

9286

H02

ICPC

Hearing complaint

1.6

59.8

1899

12021

WX320

NOMESCO Finland

Spinalanesthesy

1.4

59.8

4042

29706

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

59.8

1414

8292

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

59.7

4606

34561

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

59.7

519

2068

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

3.5

59.5

289

790

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

4.0

59.5

246

586

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

7.5

59.4

145

186

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

59.3

1150

6355

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

59.2

1151

6365

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

59.1

958

4988

-50

ICPC

Medication/prescr/renewal

2.1

59.0

730

3427

1410

FHL

Laparoscopy

2.3

58.9

553

2291

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

58.9

739

3489

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.2

58.8

609

2644

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

58.7

1501

8988

M50

ICD-10 Finland

Cervical disc disorders

6.2

58.7

165

258

J04.0

ICD-10 Finland

Acute laryngitis

2.3

58.6

570

2404

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.2

58.5

599

2588

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.4

58.5

220

479

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

58.3

730

3445

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

58.2

808

3973

R49.01

ICD-10 Finland

Functional dysphonia

2.3

58.2

551

2293

C03AA03

ATC

hydrochlorothiazide; oral

1.6

58.2

1551

9394

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.6

58.1

440

1626

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.7

58.0

1431

8487

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

57.9

700

3255

S04

ICPC

Lump/swelling localized

1.6

57.8

1574

9583

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

57.8

492

1939

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

57.7

564

2384

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

2.5

57.4

469

1808

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.8

57.3

380

1294

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

57.3

1943

12484

N89

ICPC

Migraine

2.3

57.2

533

2200

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

18.4

57.1

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

191.8

57.0

M15.8

ICD-10 Finland

Other polyarthrosis

3.2

56.9

315

951

M67.4

ICD-10 Finland

Ganglion

1.8

56.9

1138

6347

A08

ICPC

Swelling

2.1

56.8

687

3197

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

56.6

1037

5625

TQW40

SPAT

2.2

56.6

591

2578

M41.5

ICD-10 Finland

Other secondary scoliosis

54.3

56.4

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23321

193976

1.94

323.01

6.3

5.3

39.8

39.4

mmol/mol

10.47

22078

179808

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

24362

205901

2.09

319.74

5.1

4.2

6.0

5.9

mmol/l

18.04

22875

188951

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3848

19324

2.04

319.15

1.9

1.7

—

(3023368) Bacteria identified in Blood by Culture

7927

50035

1.71

315.53

4.3

4.2

—

(3002582) Erythrocytes [#/volume] in Urine

8889

57894

1.68

314.26

3.6

3.0

60.9

91.5

e6/l

1.13

7097

43246

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12505

88865

1.62

311.48

3.1

2.8

115.5

124.6

ug/l

3.70

11731

82823

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3203

15174

2.14

309.84

2.7

2.6

68.1

66.4

ml/min/173m2

1.53

1260

5824

(3019198) Lymphocytes [#/volume] in Blood

15147

102220

1.91

307.65

6.2

5.7

2.0

1.9

e9/l

5.10

13683

89634

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10311

54920

2.25

307.65

2.4

2.0

179.4

211.2

u/l

2.49

9790

51436

(3030467) Casts [#/volume] in Urine by Automated count

8458

52755

1.75

307.65

3.5

2.9

0.3

0.5

e6/l

6.64

6669

38550

(3037522) Nuclear Ab [Titer] in Serum

5056

25959

2.04

307.65

1.4

1.3

505.3

554.7

titre

1.04

990

5313

(3013115) Eosinophils [#/volume] in Blood

15288

102812

1.93

307.65

6.3

5.9

0.2

e9/l

6.46

13778

89863

(3013707) Erythrocyte sedimentation rate by Westergren method

21435

149163

2.66

307.65

4.9

3.6

11.5

11.8

mm/h

2.62

20306

137718

(3006315) Basophils [#/volume] in Blood

14887

99360

1.92

307.65

6.1

5.7

0.0

e9/l

7.26

13182

85591

(3037467) Urinalysis macro (dipstick) panel - Urine

19021

138943

1.98

307.65

5.1

3.9

—

(3044889) 12 lead EKG panel

19004

144480

1.81

307.65

4.3

3.4

—

(3018095) Leukocytes [#/volume] in Urine

10407

68606

1.71

307.65

4.2

3.4

71.3

101.4

e6/l

4.57

7817

46770

(3020564) Creatinine [Moles/volume] in Serum or Plasma

26250

228341

3.08

307.65

20.0

14.3

75.2

75.9

umol/l

3.58

26242

228219

(3026493) Urate [Moles/volume] in Serum or Plasma

8240

51466

1.74

307.65

2.6

2.5

2227.2

4497.1

umol/l

9.49

7173

45147

(3009261) Glucose [Presence] in Urine by Test strip

14934

98934

1.95

307.65

4.6

3.3

0.0

estimate

0.48

2334

18115

(3029937) Albumin [Presence] in Urine by Test strip

8785

51013

1.93

307.65

5.2

3.6

0.0

estimate

0.47

2341

17835

(3024561) Albumin [Mass/volume] in Serum or Plasma

12945

83795

1.88

307.65

4.6

4.8

36.1

35.6

g/l

25.30

12122

77790

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3294

14276

2.35

307.65

2.7

2.2

5.1

8.3

ug/l

18.30

2979

12476

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5751

32113

1.89

307.65

3.0

2.6

1.2

e6/l

0.04

3573

17475

(3021601) Nitrite [Presence] in Urine by Test strip

14769

97949

1.93

307.65

5.7

4.5

0.0

estimate

0.05

2384

18604

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23864

194397

2.26

307.65

5.7

4.5

2.0

2.2

mu/l

0.80

22510

178556

(3013650) Neutrophils [#/volume] in Blood by Automated count

16758

115933

1.96

307.65

8.5

9.3

4.2

4.1

e9/l

4.73

14983

100797

(3015736) pH of Urine

12061

74957

1.94

307.65

4.3

3.0

5.3

5.8

—

(40761535) Cells panel - Urine sediment

3692

13810

2.78

307.65

4.2

3.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

18834

130595

2.18

307.65

5.5

3.9

1559.9

1565.6

e6/l

0.00

210

1836

(3020891) Body temperature

1830

6610

2.74

307.65

5.0

4.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10715

59543

2.16

307.65

2.8

2.5

54.5

59.3

u/l

17.65

10005

54829

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15565

102535

2.02

307.65

5.5

6.3

10.2

11.5

umol/l

36.30

14816

97135

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13369

86060

1.93

307.65

6.0

5.9

1.2

mmol/l

4.11

12391

77849

(3026008) Bacteria identified in Urine by Culture

9216

55961

1.85

307.65

3.5

2.8

—

(3001604) Monocytes [#/volume] in Blood

14824

98907

1.92

307.65

6.1

5.7

0.6

e9/l

3.67

13135

85226

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

11161

67814

1.95

307.65

3.8

3.1

—

0.2

—

(3008898) HLA-B27 [Presence]

1639

5347

3.03

307.65

1.1

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7672

46693

1.78

307.65

2.4

2.2

2.9

mg/l

0.95

6764

39796

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21057

161413

2.02

307.65

4.8

3.9

14.7

pmol/l

2.10

19665

147379

(36304419) Bacteria [Presence] in Urine

8246

51558

1.74

307.65

3.5

2.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

8463

43735

2.21

307.65

4.7

3.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

9938

65932

1.68

307.65

2.9

3.6

2.4

mmol/l

1.51

8855

57822

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11811

70479

2.04

307.65

4.1

3.1

53.6

60.9

ng/l

0.27

7781

45238

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21469

156207

2.40

307.65

7.8

7.3

75.8

78.0

u/l

10.23

20506

146792

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13950

93758

1.84

307.65

4.4

3.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11531

75733

1.77

307.65

4.8

3.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11903

78618

1.77

307.65

2.1

1.9

95.7

96.6

pmol/l

1.20

6358

40959

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4801

22700

2.22

307.65

8.5

6.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7841

41864

2.09

307.65

1.9

1.7

1.0

1.3

mg/l

16.42

5984

32028

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8318

50433

1.81

307.65

3.0

2.9

963.4

1372.9

ng/l

24.30

7170

42833

(3007853) Bacteria identified in Skin by Aerobe culture

4260

22012

1.99

307.65

1.9

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

25952

218102

3.37

307.65

19.8

14.1

4.0

mmol/l

13.58

25622

211653

(3013826) Glucose [Moles/volume] in Serum or Plasma

17071

114765

2.09

307.65

5.2

4.5

6.6

6.7

mmol/l

13.76

16205

106439

(3035350) Ketones [Presence] in Urine by Test strip

14799

97415

1.96

307.65

4.5

3.2

0.0

estimate

0.05

2314

18222

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7177

43404

1.77

307.65

1.3

1.8

u/ml

3.00

2129

11866

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14570

95457

1.96

307.65

6.6

6.5

1.2

mmol/l

2.69

12801

79910

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25637

211495

3.28

307.65

18.1

12.2

20.7

23.9

mg/l

48.35

21543

163396

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6634

29981

2.45

307.65

1.4

1.2

7.3

13.8

u/ml

11.66

2673

11849

(3019550) Sodium [Moles/volume] in Serum or Plasma

25914

217332

3.35

307.65

19.7

14.0

139.6

139.7

mmol/l

3.28

25609

211307

(3018418) pH of Serum or Plasma

9263

56211

1.85

307.65

3.9

4.1

7.4

0.98

1409

11088

(3000850) Epithelial cells [#/volume] in Urine

6811

38770

1.89

307.65

2.7

2.5

5.6

5.9

e6/l

0.78

6068

33597

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11906

82680

1.65

307.65

2.5

2.2

76.1

77.0

nmol/l

3.03

10939

74707

(3019150) Specific gravity of Urine by Refractometry

8022

39877

2.28

307.65

5.2

3.5

1.0

kg/l

0.52

883

6324

(3032080) INR in Blood by Coagulation assay

11364

76810

1.69

307.65

8.2

1.2

inr

4.75

3110

22361

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6949

32017

2.42

307.65

1.4

1.2

30.0

40.6

iu/ml

3.38

2024

10365

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5129

28720

1.85

306.76

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3785

19261

2.00

301.18

1.8

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

9390

62588

1.64

300.04

2.5

2.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6042

35759

1.77

299.97

4.2

3.3

312.3

608.2

ng/l

4.82

4296

26940

(3019060) Gas panel - Arterial blood

2518

11059

2.28

293.04

4.7

5.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2431

10563

2.30

290.05

7.5

7.2

24.7

24.5

mmol/l

1.61

2291

9837

(40758558) Short blood count panel - Blood

7863

50495

1.67

288.03

6.1

7.1

—

(3016502) Oxygen saturation in Arterial blood

3555

18033

2.00

284.23

6.6

8.2

95.8

95.7

0.55

3428

17381

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5799

34377

1.76

284.14

2.7

3.1

2.4

2.5

mmol/l

8.31

5106

30064

(3048689) Calprotectin [Mass/mass] in Stool

4307

23380

1.89

281.50

2.1

2.3

114.8

132.9

ug/g

3.09

3432

18341

(40761511) CBC panel - Blood by Automated count

25722

224058

2.42

280.06

16.3

11.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3877

20370

1.94

279.59

6.4

7.8

5.1

kpa

0.41

3724

19488

(3027801) Oxygen [Partial pressure] in Arterial blood

3874

20357

1.94

279.23

6.4

7.8

12.1

12.7

kpa

11.45

3728

19466

(3021960) Folate [Moles/volume] in Serum or Plasma

6851

42715

1.70

279.11

1.6

1.5

20.7

20.5

nmol/l

0.40

6061

36671

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26144

229633

2.69

275.69

12.3

9.4

26.9

26.4

u/l

2.56

25604

221544

(3003396) Base excess in Arterial blood by calculation

3867

20398

1.93

275.26

6.4

7.7

1.3

0.9

mmol/l

6.79

3026

16175

(3019309) Folate [Moles/volume] in Red Blood Cells

5606

33182

1.76

274.95

1.8

1.7

1233.0

1153.6

nmol/l

8.72

4558

24913

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1802

7038

2.53

271.91

1.3

1.2

0.8

0.9

u/ml

0.10

276

492

(3022217) INR in Platelet poor plasma by Coagulation assay

4240

23141

1.87

271.61

21.7

22.9

1.3

inr

1.24

594

3327

(3042936) Bacteria identified in Isolate by Culture

4675

26463

1.82

265.77

2.2

2.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

1421

5006

2.79

263.25

4.6

4.5

3.9

mmol/l

0.91

1386

4667

(3033658) Prothrombin time (PT) actual/Normal

7774

50739

1.63

262.23

4.0

3.9

93.7

91.2

15.98

7488

49573

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3302

16795

1.98

260.42

7.0

8.7

123.5

121.2

g/l

7.94

3200

16208

(4010399)

2761

13219

2.09

257.12

1.5

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4202

23324

1.84

253.51

6.5

7.4

104.3

104.5

mmol/l

3.52

4126

22838

(3018405) Lactate [Moles/volume] in Arterial blood

1552

5852

2.61

251.38

4.4

4.3

1.3

1.4

mmol/l

0.75

1537

5756

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7290

47279

1.63

249.97

2.4

2.2

—

(40768797) Stomach Pathology biopsy report

4557

26030

1.79

249.75

1.3

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

12815

94784

1.53

246.31

6.5

6.1

8.4

8.6

5.71

12062

88913

(3006504) Eosinophils/100 leukocytes in Blood

12745

94285

1.53

243.83

6.3

5.8

2.9

2.8

1.03

11941

87933

(3022096) Basophils/100 leukocytes in Blood

12396

91386

1.52

239.45

6.3

5.9

0.7

1.64

11616

85293

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9642

67401

1.55

237.35

3.4

3.2

31.0

34.0

u/l

4.85

9179

63940

(3018010) Neutrophils/100 leukocytes in Blood

12919

96252

1.52

236.27

6.2

5.7

56.6

57.3

10.47

12149

90232

(3002030) Lymphocytes/100 leukocytes in Blood

13062

97818

1.51

231.20

6.4

5.9

28.7

28.0

9.77

12252

91292

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3210

16854

1.91

228.62

2.2

2.3

357.5

382.8

nmol/l

9.59

2924

15571

(40760892) CBC W Ordered Manual Differential panel - Blood

6877

44836

1.61

226.76

4.6

4.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

6014

38062

1.64

223.23

1.5

1.4

2.3

2.4

g/l

1.19

3712

23552

(42870588) Differential panel, method unspecified - Blood

9496

67250

1.52

214.33

6.0

5.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5766

36607

1.63

209.39

1.7

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

8791

61553

1.52

207.69

3.3

3.2

7.6

mmol/l

0.24

7591

51833

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2544

12833

1.97

202.59

2.4

2.3

25.0

22.6

au/ml

0.30

891

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2531

12846

1.96

197.77

1.7

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2349

11659

2.00

195.63

1.3

44.1

48.4

au/ml

0.39

541

(3014007) Fractional oxyhemoglobin in Arterial blood

2306

11380

2.01

195.17

7.6

10.0

93.8

94.0

0.95

2297

11339

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2288

11352

2.00

190.54

7.5

9.8

1.6

1.3

14.57

2271

11279

(3007461) Platelets [#/volume] in Blood

26722

241340

2.92

187.89

26.4

18.1

256.9

253.3

e9/l

15.90

26366

234596

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2275

11352

1.98

186.23

7.6

9.9

0.7

11.72

2263

11286

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4953

31092

1.62

185.35

2.9

3.5

0.8

mmol/l

0.20

4612

29102

(3035941) MCH [Entitic mass]

26726

241532

2.90

184.92

26.2

18.0

30.3

14.55

26573

238014

(3026782) Osmolality of Urine

5679

36855

1.58

184.89

3.0

2.6

536.5

547.5

mosm/kgh2o

3.24

4925

31157

(3024731) MCV [Entitic volume]

26729

241579

2.91

184.79

26.2

18.0

91.2

90.8

32.08

26575

238049

(3026361) Erythrocytes [#/volume] in Blood

26729

241595

2.91

184.44

26.4

18.1

4.5

e12/l

31.13

26333

234134

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2122

10376

2.02

183.86

1.6

1.5

—

(3010813) Leukocytes [#/volume] in Blood

26728

241633

2.90

183.32

26.4

18.1

6.9

6.6

e9/l

48.75

26330

234163

(3000963) Hemoglobin [Mass/volume] in Blood

26729

241678

2.89

182.65

26.5

18.2

135.1

135.9

g/l

17.02

26578

238180

(3003338) MCHC [Mass/volume]

21760

185115

1.56

181.73

23.5

15.6

332.3

332.4

g/l

1.29

21649

183714

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24734

217401

1.81

180.45

5.4

4.6

2.8

mmol/l

17.84

23299

201239

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4653

29107

1.62

175.50

2.0

2.1

29.4

29.8

4.45

4527

28264

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17616

143993

1.45

175.33

3.6

2.9

50.3

46.6

u/l

4.88

16675

135007

(3014111) Lactate [Moles/volume] in Serum or Plasma

2900

15994

1.81

173.74

6.1

7.5

1.3

1.4

mmol/l

0.06

2819

15461

(4034850)

1395

5943

2.29

171.70

11.6

8.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6037

40498

1.53

167.02

1.7

1.6

40430916.9

30622271.8

pmol/l

0.59

5157

33610

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

23293

202286

1.61

166.96

14.8

11.7

83.1

82.6

ml/min/173m2

2.85

19773

165367

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24334

213855

1.71

164.19

4.8

4.1

4.7

mmol/l

25.37

23044

199048

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4761

30448

1.59

162.32

3.3

2.7

3.5

2.9

e6/l

2.96

2631

15883

(3005322) IgE [Units/volume] in Serum or Plasma

2297

12025

1.89

162.07

1.3

217.7

255.3

u/ml

0.84

2125

11145

(3012516) Albumin [Mass/volume] in Urine

8044

57532

1.46

161.45

3.3

541.1

335.1

mg/l

2.77

5255

35832

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1710

8133

2.06

159.14

3.1

2.9

1.5

1.2

13.10

1702

8092

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2929

16648

1.75

157.36

3.8

3.9

5.9

5.8

kpa

4.18

2852

16181

(3002032) Base excess in Venous blood by calculation

2907

16595

1.74

153.57

3.9

2.1

1.8

mmol/l

4.12

2380

13628

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1668

7980

2.05

152.60

3.1

2.8

0.7

0.11

1575

7692

(3014765) Yersinia sp identified in Stool by Organism specific culture

1246

5316

2.28

152.51

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

2465

13435

1.81

152.51

3.4

3.1

4.6

4.7

kpa

1.45

2394

13000

(3012544) pH of Venous blood

2992

17270

1.72

151.82

3.8

3.9

7.4

0.23

(3020682) Albumin/Creatinine [Ratio] in Urine

8344

60712

1.44

150.39

3.9

4.0

7.6

9.2

mg/mmol

2.92

5356

38095

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24121

212387

1.64

149.89

4.7

4.1

1.4

1.5

mmol/l

50.10

22717

196898

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1231

5263

2.28

149.89

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1242

5332

2.27

149.75

1.2

—

(3000494) Fungus identified in Specimen by Culture

3713

22810

1.63

148.26

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2145

11390

1.85

144.05

2.3

2.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3640

22434

1.62

143.02

2.6

2.7

6.4

8.9

umol/l

13.32

3124

19496

(3021589) Normoblasts [#/volume] in Blood

11794

91813

1.38

141.24

9.7

9.0

0.0

e9/l

0.02

9788

74978

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3894

24497

1.59

140.27

5.1

6.1

1.0

mmol/l

0.01

3643

22902

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1597

7772

2.01

139.01

3.9

51.5

47.7

7.72

1581

7686

(3020630) Protein [Mass/volume] in Serum or Plasma

2524

14240

1.75

138.18

2.4

2.5

67.0

66.4

g/l

3.53

2309

13007

(3013139) Helicobacter pylori Ag [Presence] in Stool

2341

12972

1.78

136.31

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

16876

139732

1.38

135.37

3.3

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1252

5642

2.16

133.73

1.7

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3031

18125

1.66

133.61

2.9

2.4

43.6

47.3

u/l

0.17

2599

15600

(3000991) Gas panel - Venous blood

2663

15447

1.70

131.60

7.1

8.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23331

205062

1.53

131.46

4.3

3.7

1.4

1.3

mmol/l

80.09

21845

189093

(3022948) Iron [Moles/volume] in Serum or Plasma

4575

30294

1.52

130.10

2.5

13.3

umol/l

0.07

4252

28117

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2408

13629

1.74

129.97

3.5

4.0

81.6

92.9

ng/l

7.95

2164

11741

(3004119) Hemoglobin [Mass/volume] in Venous blood

2013

10810

1.83

129.87

3.5

3.3

129.9

129.1

g/l

0.99

1963

10580

(3005719) IgG [Mass/volume] in Serum or Plasma

2482

14180

1.73

129.53

2.6

10.2

10.7

g/l

8.16

2276

12995

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1034

4423

2.27

125.46

1.3

545.9

547.4

mg/l

0.01

992

4210

(3025941) Bacteria identified in Stool by Culture

2033

11121

1.79

123.14

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

953

3984

2.32

122.02

1.7

1.6

12405.8

14159.1

e6/l

0.38

700

2881

(3045414) Leukocytes [Presence] in Urine

1616

8249

1.91

122.00

1.9

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

940

3925

2.32

120.67

1.4

966.3

2103.5

e6/l

0.99

799

3095

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

937

3925

2.31

119.39

1.3

1.4

17.1

34.3

e6/l

1.93

755

2939

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

923

3882

2.30

116.47

1.2

3.7

mmol/l

0.29

873

3641

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1123

5121

2.13

116.12

1.4

283.2

270.7

ug/g

1.10

626

2968

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3906

25599

1.52

115.13

2.0

1.7

1.5

1.4

14.02

3451

22726

(3004716) Salmonella sp identified in Stool by Organism specific culture

1820

9944

1.79

110.27

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1616

8526

1.85

109.80

3.4

25.3

25.2

mmol/l

1.00

1575

8286

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4163

27973

1.49

108.09

2.5

2.4

2.3

g/l

8.98

3886

25842

(3020961) Endomysium IgA Ab [Titer] in Serum

1687

9157

1.80

104.32

1.1

287.1

237.1

titre

0.17

261

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2433

14690

1.63

101.63

2.9

2.7

155.3

206.4

ng/l

7.69

2211

13346

(3027945) Reticulocytes/100 erythrocytes in Blood

3158

20273

1.54

101.38

2.2

2.5

1.8

0.25

2850

17981

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1364

7026

1.89

99.71

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3861

25955

1.48

99.20

2.5

2.6

22.3

23.0

2.71

3307

22358

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1187

5865

1.96

98.28

1.6

1.7

1.2

g/l

4.62

1127

5587

(3028707) Methadone [Presence] in Urine by Screen method

706

2880

2.36

95.49

4.1

2.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1148

5692

1.95

94.03

1.6

1.7

0.2

g/l

0.54

1084

5399

(3002385) Erythrocyte distribution width [Ratio]

20534

179424

1.34

91.06

20.2

15.2

13.7

13.6

7.32

20242

175362

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

316

857

3.53

90.85

1.6

1.4

5.0

6.6

u/l

3.28

274

726

(3023520) Reticulocytes [#/volume] in Blood

2399

14849

1.58

89.83

2.2

2.6

70.2

69.6

e9/l

0.36

1849

11035

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

948

4499

2.04

87.86

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1689

9671

1.70

86.08

2.5

2.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

667

2789

2.30

85.20

1.3

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2125

12948

1.60

84.81

3.2

3.5

4.4

4.5

pmol/l

2.71

1897

11616

(40757494) Bilirubin.total [Moles/volume] in Blood

307

855

3.44

84.77

2.0

2.2

16.1

24.7

umol/l

0.81

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1390

7584

1.78

84.04

1.1

13.9

5.5

u/ml

0.31

112

(40768804) Tissue Pathology biopsy report

10735

86754

1.29

82.66

2.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

300

838

3.42

82.47

1.3

1.2

233.5

410.5

u/l

1.68

286

777

(36660697) Celiac disease serology panel - Serum

2466

15648

1.54

82.41

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1454

8105

1.74

81.56

1.3

1.6

11.4

15.7

u/ml

0.41

252

(3047181) Lactate [Moles/volume] in Blood

1073

5455

1.90

81.42

5.3

6.0

1.3

mmol/l

1.14

949

4804

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2982

19772

1.48

80.77

2.0

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1216

6468

1.82

79.97

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1863

11165

1.63

79.40

1.7

1.9

1.2

1.3

g/l

1.99

1714

10193

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1437

8087

1.72

77.83

1.9

2.0

39.6

39.3

u/l

0.14

1308

7210

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1034

5300

1.89

76.47

1.3

1.2

17.9

41.0

u/ml

3.15

344

(3011288) Drugs identified in Urine by Screen method

945

4722

1.93

75.49

4.3

2.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3240

22123

1.44

74.95

2.2

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

743

3424

2.09

74.49

1.4

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

962

4860

1.91

74.35

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

703

3200

2.11

72.80

1.8

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1692

10131

1.62

72.17

1.1

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3143

21490

1.44

71.96

3.7

4.4

240.7

243.5

u/l

0.32

2981

20402

(3044941) Cell count panel - Synovial fluid

602

2596

2.23

71.45

1.5

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1729

10441

1.61

71.20

1.7

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

412

1508

2.62

70.29

1.4

127196.6

116834.9

e6/l

0.10

302

1018

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1051

5567

1.82

69.96

1.5

1.6

5.6

5.4

iu/ml

0.01

229

1098

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

801

3911

1.97

68.43

1.3

1.2

38.4

43.5

u/ml

0.39

399

(1761868) Lipid panel - Serum or Plasma

7393

83503

0.78

66.62

2.8

2.7

—

(3014051) Protein [Presence] in Urine by Test strip

810

4009

1.95

66.52

2.2

2.0

—

(3013512) EKG study

7197

56436

1.29

66.38

4.1

3.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

508

2104

2.32

66.38

1.5

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3344

23431

1.40

66.31

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1284

7317

1.70

66.24

4.8

5.0

1.8

1.7

5.49

1212

6875

(3044290) Cell count panel - Cerebral spinal fluid

772

3765

1.97

66.17

1.3

1.4

—

(3022145) Colonoscopy Study observation

3227

22510

1.41

65.62

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

932

4876

1.84

64.54

1.3

9.8

7.5

u/ml

0.35

135

782

(3026389) Candida sp identified in Specimen by Organism specific culture

599

2687

2.14

64.43

1.5

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1254

7163

1.69

64.09

5.0

5.1

0.9

1.74

1183

6730

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3339

23516

1.40

64.07

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1111

6142

1.75

63.92

2.1

2.3

452.5

591.6

ug/l

0.93

1031

5774

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1137

6329

1.74

63.85

1.5

1.6

161.5

288.7

titre

1.03

259

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1169

6584

1.72

62.92

2.1

3.7

3.9

g/l

1.50

868

4762

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1170

6605

1.71

62.43

2.1

7.4

g/l

0.64

898

5000

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1168

6598

1.71

62.18

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1113

6229

1.73

61.28

2.1

3.0

3.1

g/l

1.18

886

4906

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

911

4816

1.82

60.98

1.3

7.5

5.9

u/ml

0.18

506

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1618

9976

1.57

60.75

8.3

10.3

—

(3022621) pH of Urine by Test strip

1952

12569

1.51

60.13

3.2

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1018

5601

1.75

59.53

3.5

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

724

3587

1.94

59.27

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1939

12510

1.51

59.13

2.1

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

782

3979

1.89

59.08

1.3

1.2

3.0

6.2

u/ml

1.02

303

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

772

3912

1.90

59.06

1.3

1.2

0.6

15.8

u/ml

2.49

(3000492) Spirometry study

2861

19897

1.41

58.75

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

285

948

2.87

58.50

1.1

2.2

7.2

nmol/l

1.43

204

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2163

14314

1.47

58.13

1.2

126.6

153.4

iu/ml

2.54

877

5460

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

232

688

3.22

58.10

2.0

1.7

117.4

128.8

umol/l

0.24

126

337

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1570

9711

1.57

58.07

1.9

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

1022

5692

1.73

57.22

3.1

3.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

208

583

3.40

57.02

1.2

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1090

6197

1.70

56.61

2.1

9.8

10.3

g/l

4.09

929

5216

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1416

8636

1.59

55.62

4.4

4.3

24.3

24.1

mmol/l

1.62

1206

7838

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

174

446

3.72

54.57

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2457

16844

1.42

54.52

6.6

7.8

9.2

9.7

mmol/l

3.30

2340

16061

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

433

1824

2.27

54.44

1.1

71.7

99.3

au/ml

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

440

1867

2.26

54.37

1.1

74.0

6.6

au/ml

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

357

1382

2.47

54.31

1.2

1.1

40.0

45.0

mg/l

0.95

307

1142

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6871

54693

1.26

53.60

1.7

1.6

1.5

1.4

mmol/l

23.02

5878

46024

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

346

1329

2.49

53.53

1.1

267.0

269.7

mg/l

0.07

305

1161

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1547

9727

1.54

53.07

2.7

2.6

0.3

e6/l

0.28

1507

9439

(3039000) Anion gap in Blood

735

3818

1.85

52.05

6.1

7.1

11.1

11.3

mmol/l

0.82

669

3444

(3018572) Chloride [Moles/volume] in Blood

735

3819

1.85

52.01

6.1

7.1

105.1

105.2

mmol/l

0.20

669

3445

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

336

1292

2.49

51.87

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1713

11069

1.50

51.64

3.4

5.2

5.1

kpa

4.27

1596

10229

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

549

2606

2.02

50.83

1.2

1.3

0.2

0.3

nmol/l

0.31

160

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

743

3904

1.83

50.72

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1206

7240

1.61

50.55

2.5

2.2

5772.5

5260.8

u/l

0.21

405

2941

(3021788) Differential panel - Synovial fluid

632

3162

1.92

50.27

1.5

—

(3009343) pH of Capillary blood

1682

10916

1.49

49.59

3.4

7.4

0.01

203

1475

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1632

10536

1.50

49.36

3.3

1.9

1.7

mmol/l

1.21

1225

7754

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

985

5660

1.68

49.11

2.2

2.3

0.7

0.8

g/l

0.70

867

4847

(4027681)

288

1059

2.60

48.83

1.2

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1161

6972

1.61

48.58

2.2

1.9

1.8

2.3

ug/l

1.07

1039

6181

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

542

2605

1.99

48.48

1.2

1.3

0.6

1.8

nmol/l

1.20

524

2509

(21494755) Public health laboratory ask at order entry panel

1883

24936

0.70

48.12

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

894

5037

1.71

47.97

2.0

2.1

0.0

g/l

1.54

829

4590

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1023

6006

1.64

46.91

2.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

909

5207

1.68

45.85

2.0

2.1

38.0

37.7

g/l

0.70

804

4456

(3013166) Neutrophils/100 leukocytes in Synovial fluid

163

450

3.45

45.85

1.3

1.4

53.5

54.3

0.09

137

389

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2060

14103

1.42

45.72

2.4

2.1

12.0

12.6

nmol/l

2.10

1802

12661

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

496

2366

2.01

45.34

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

885

5054

1.68

45.16

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

295

1147

2.46

44.55

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

1207

7463

1.56

44.53

3.2

1.8

—

(3016879) Cocaine [Presence] in Urine

1132

6903

1.58

44.36

3.3

1.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

495

2380

1.99

44.26

1.3

1.2

39.7

57.9

u/ml

0.99

151

(3028300) Cannabinoids [Presence] in Urine

1212

7534

1.55

43.66

3.3

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

589

3020

1.87

43.50

1.4

1.6

0.6

0.8

g/l

6.03

442

2266

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

256

947

2.58

42.94

1.1

1.0

1.1

u/l

1.06

119

428

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

290

1141

2.43

42.70

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1707

22550

0.70

42.66

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

361

1566

2.20

42.38

1.4

1.6

30.6

31.7

0.22

220

986

(3027008) Opiates [Presence] in Urine

1204

7523

1.54

42.36

3.0

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1512

9914

1.47

42.20

8.1

10.0

24.4

24.3

mmol/l

1.26

1391

9344

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

821

4683

1.68

42.08

2.0

2.1

0.0

g/l

0.01

757

4252

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

375

1658

2.16

41.99

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

408

1865

2.09

41.92

1.4

1.3

6.1

7.0

g/l

7.07

296

1268

(3024139) IgG subclass 3 [Mass/volume] in Serum

407

1862

2.09

41.72

1.4

1.3

0.4

g/l

0.02

298

1265

(3028192) IgG subclass 2 [Mass/volume] in Serum

407

1864

2.09

41.60

1.4

1.3

2.9

3.0

g/l

1.29

294

1265

(44813793)

318

1319

2.30

41.58

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

2300

16292

1.37

41.52

4.0

4.1

0.9

1.0

0.57

655

4534

(3019420) Tryptase [Mass/volume] in Serum or Plasma

256

964

2.53

41.41

1.5

8.7

7.7

ug/l

0.24

234

866

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

810

4628

1.68

41.26

2.1

0.0

g/l

0.00

753

4244

(46235355) HIV 1 and 2 tests - Meaningful Use set

4715

36875

1.26

41.09

1.8

—

(4062490)

404

1856

2.08

40.97

1.4

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2565

18519

1.35

40.92

2.2

2.3

0.2

g/l

4.79

2370

17302

(3024263) Appearance of Synovial fluid

232

838

2.64

40.86

1.6

—

(3027944) Amphetamines [Presence] in Urine

1181

7423

1.53

40.43

3.2

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

617

3301

1.79

39.72

1.4

1.3

27.8

30.0

u/l

0.88

515

2726

(3009214) Lutropin [Units/volume] in Serum or Plasma

933

5579

1.61

39.70

1.3

11.1

10.9

u/l

0.17

768

4594

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

649

3535

1.76

39.31

1.2

72.0

121.7

titre

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

468

2302

1.95

39.23

6.6

6.1

12.1

11.4

mg/l

2.72

436

2105

(3041096) Erythrocytes [Presence] in Urine by Automated

6750

55177

1.21

38.40

3.7

3.0

—

(44790049)

416

1984

2.01

38.12

1.5

—

(44806118)

416

1984

2.01

38.12

1.5

—

(44790048)

416

1985

2.00

38.07

1.5

—

(44790047)

416

1985

2.00

38.07

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

925

5577

1.59

38.03

1.4

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

687

3843

1.71

37.87

2.0

1.8

184.2

198.1

pmol/l

3.07

641

3652

(3037756) Immunofixation for Serum or Plasma

636

3528

1.73

36.15

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

2165

15518

1.35

36.03

4.0

4.1

0.2

0.1

2.00

579

4222

(3002179) Metamyelocytes/100 leukocytes in Blood

2073

14809

1.36

35.23

3.8

4.0

0.5

0.7

1.07

433

3318

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

578

3152

1.76

34.90

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1260

8275

1.47

34.79

1.6

1.7

1.6

1.5

g/l

2.22

1103

7082

(3011985) Renin [Units/volume] in Plasma

502

2639

1.82

34.31

1.5

59.8

64.6

mu/l

0.27

450

2351

(3015235) Bicarbonate [Moles/volume] in Capillary blood

753

4454

1.62

33.52

2.9

24.8

24.6

mmol/l

0.67

645

3908

(3028626) Oxygen [Partial pressure] in Capillary blood

667

3840

1.66

33.05

2.8

8.2

kpa

0.25

617

3555

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

733

4331

1.62

32.78

1.5

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

355

1690

2.01

32.77

2.2

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

855

5258

1.56

32.29

2.1

10.7

11.0

mg/l

0.60

798

4921

(3017732) Neutrophils [#/volume] in Blood

1943

13933

1.35

32.12

2.6

2.9

4.1

e9/l

0.34

1553

10872

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

870

5405

1.55

31.40

3.2

40.2

42.4

mg/l

0.12

737

4364

(3049717) Cytology report of Urine Cyto stain

1022

6577

1.49

31.24

2.4

2.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

319

1492

2.04

30.95

1.8

1.4

1.3

promille

0.67

237

1169

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

883

5531

1.53

30.70

1.9

1.7

39.8

41.9

nmol/l

1.97

867

5394

(3034860) Kappa light chains.free [Mass/volume] in Serum

868

5418

1.54

30.67

3.2

45.2

54.2

mg/l

1.74

737

4373

(3025159) Blasts/100 leukocytes in Blood

2014

14624

1.33

30.55

4.0

4.2

0.2

0.06

459

3588

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

704

4191

1.61

30.55

1.5

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

493

2673

1.76

30.43

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

351

1709

1.96

30.43

1.4

1.3

1.6

1.4

nmol/l

2.92

328

1525

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1122

15063

0.69

30.26

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5722

46969

1.20

29.78

4.3

3.9

21.9

21.8

0.15

2611

21877

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

842

5258

1.54

29.69

3.1

1.6

5.2

ratio

1.79

395

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

122

4.99

29.54

1.1

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

882

5581

1.52

29.26

1.1

2.9

6.0

u/ml

3.23

809

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3932

31165

1.23

29.25

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

651

3844

1.62

29.23

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

650

3844

1.62

29.00

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1133

7550

1.44

28.96

1.7

1.6

—

(4198724)

197

778

2.41

28.96

3.4

1.8

—

(3042517) Benzodiazepines panel - Urine

166

4.30

28.92

3.3

2.7

—

(3023419) Bacteria identified in Sputum by Culture

408

2139

1.82

28.22

2.7

2.5

—

(3003181) Sodium [Moles/volume] in Urine

529

2998

1.69

27.89

1.4

1.3

63.4

62.4

mmol/l

0.23

425

2331

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

817

5144

1.52

27.75

1.9

35.0

10.5

iu/l

0.74

300

1970

(40760888) Immunoglobulin light chains.free panel - Serum

665

4002

1.59

27.61

3.3

—

(3034770) Mitochondria Ab [Titer] in Serum

872

5574

1.50

27.56

1.2

674.1

964.3

titre

0.77

179

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

450

2449

1.76

27.47

1.3

1.4

294.7

308.3

pmol/l

0.27

366

1887

(3022313) Gas panel - Capillary blood

1166

7892

1.42

27.35

3.6

3.5

—

(3000330) Specific gravity of Urine by Test strip

1353

9424

1.38

26.83

3.5

3.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

209

877

2.27

26.80

1.2

1.3

71.4

59.5

0.77

106

(3023410) Appearance of Cerebral spinal fluid

368

1905

1.84

26.55

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

170

654

2.48

26.50

1.2

0.3

g/l

0.05

135

519

(3021387) Prolactin [Units/volume] in Serum or Plasma

1064

7126

1.43

26.46

1.6

1.7

315.3

311.8

mu/l

0.09

956

6427

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

309

1513

1.95

26.43

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

309

1513

1.95

26.43

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

309

1513

1.95

26.43

1.5

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

430

2338

1.76

26.35

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

337

1706

1.89

26.09

1.4

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

160

603

2.53

26.05

1.2

109.5

112.6

0.73

140

540

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

363

1889

1.84

25.77

1.4

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1587

11409

1.34

25.68

6.7

7.4

25.1

24.7

mmol/l

4.81

1573

11297

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

770

4871

1.51

25.60

2.1

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

203

860

2.25

25.47

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

869

5642

1.48

25.45

1.2

118.5

125.7

titre

0.10

505

(3035637) Corticotropin [Mass/volume] in Plasma

430

2368

1.74

25.22

1.6

1.5

—

(40768443) Skin Pathology biopsy report

1262

8791

1.38

25.01

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

421

2321

1.73

24.61

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

21849

200205

1.18

24.30

18.2

13.4

40.0

39.9

0.22

15255

150717

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1464

1.92

23.97

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1465

1.91

23.93

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

518

3042

1.63

23.85

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1467

1.91

23.83

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

281

1382

1.94

23.78

1.7

2.0

18.3

17.6

nmol/l

0.72

266

1302

(40759836) Histone Ab [Presence] in Serum by Immunoblot

292

1456

1.91

23.72

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1457

1.91

23.67

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4492

36736

1.19

23.63

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1458

1.91

23.63

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

377

2038

1.77

23.63

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1007

6817

1.42

23.61

3.7

3.6

24.9

24.8

mmol/l

0.40

943

6290

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

391

2144

1.74

23.32

1.5

1.6

53.8

56.9

0.74

227

1395

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6980

59222

1.16

23.26

4.6

2.4

2.9

ug/l

1.24

6386

53378

(3021901) Oxygen saturation in Capillary blood

545

3271

1.59

22.96

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

439

2504

1.67

22.68

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

530

3173

1.60

22.58

3.4

3.1

63.7

65.3

0.90

530

3157

(3036489) Thrombin time

1112

7724

1.38

22.43

1.8

2.0

21.0

21.5

1.63

950

6740

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

432

2464

1.67

22.33

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

783

5119

1.47

22.17

1.2

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

259

1273

1.94

22.00

2.3

3.6

88.2

136.9

nmol/l

2.83

254

1252

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

329

1746

1.80

21.99

1.5

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

808

5333

1.45

21.78

1.3

1.5

19.6

15.1

iu/ml

0.29

130

(3024928) Oxygen saturation in Venous blood

617

3870

1.53

21.42

3.5

3.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

621

3908

1.52

21.23

2.6

2.8

33.4

34.7

umol/l

0.55

527

3348

(3035947) Staphylolysin Ab [Units/volume] in Serum

189

841

2.14

21.11

1.2

1.1

2.7

3.5

iu/ml

1.42

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

716

4647

1.47

21.06

2.2

2.4

106.8

110.6

ug/min

0.09

409

2826

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

162

680

2.27

20.88

1.1

327.3

508.2

ng/l

0.22

179

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

187

835

2.13

20.71

1.5

1.6

2.6

6.3

nmol/l

0.71

161

709

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1990

15184

1.26

20.47

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

293

1547

1.81

19.97

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

946

6525

1.39

19.93

1.3

192.7

228.7

miu/ml

2.48

417

3015

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

536

3321

1.54

19.72

1.1

—

(3016038) Potassium [Moles/volume] in Urine

229

1123

1.94

19.65

1.2

1.1

35.1

34.7

mmol/l

0.07

192

975

(3023323) Follitropin [Units/volume] in Serum or Plasma

1525

11319

1.30

19.58

1.4

1.3

28.9

30.5

iu/l

1.10

1333

9864

(3002619) Bacteria identified in Specimen by Culture

340

2.77

19.51

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

244

1227

1.90

19.43

1.4

1.5

23.8

24.9

u/ml

0.10

249

(3016650) Hepatitis A virus Ab [Presence] in Serum

537

3340

1.54

19.42

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

351

1968

1.70

19.42

1.2

—

(3019225) pH of Specimen

2428

19049

1.23

19.41

4.2

4.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

268

1392

1.84

19.29

1.2

1.3

1.9

2.2

mmol/l

3.92

249

1295

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

128

503

2.42

19.21

1.6

9.5

8.9

ug/l

0.60

128

503

(3020717) Zinc [Moles/volume] in Serum or Plasma

192

896

2.04

18.97

1.5

1.4

20.0

27.1

umol/l

3.31

181

849

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

583

3712

1.50

18.90

1.7

1.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

179

816

2.09

18.84

1.6

2.5

22.0

243.6

ug/l

1.07

172

773

(3045716) Anion gap in Serum or Plasma

171

767

2.12

18.77

2.9

2.2

8.7

9.3

mmol/l

1.23

122

575

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

629

4077

1.48

18.68

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

508

3151

1.54

18.63

1.5

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

240

1226

1.87

18.24

1.1

10.8

8.4

iu/ml

0.50

327

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

461

2820

1.56

18.01

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2508

19893

1.22

17.96

3.6

3.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

8.74

17.91

1.7

1.6

110.5

239.9

nmol/l

1.33

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

508

2.36

17.91

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

177

820

2.06

17.87

2.9

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

200

969

1.97

17.83

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

138

581

2.26

17.75

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2056

16012

1.24

17.58

3.6

3.8

1.2

mmol/l

0.20

1817

13981

(3016244) Insulin [Units/volume] in Serum or Plasma

226

1147

1.88

17.55

3.5

30.1

27.7

mu/l

0.35

218

1079

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.48

17.48

1.1

1.0

0.2

0.1

u/ml

0.58

(3001186) Copper [Moles/volume] in Serum or Plasma

115

450

2.43

17.47

1.4

1.3

16.6

17.4

umol/l

0.83

103

395

(4094501)

801

5496

1.39

17.45

1.1

—

(3008295) Osmolality of Serum or Plasma

313

1754

1.70

17.41

1.3

1.5

278.7

280.2

mosm/kgh2o

0.60

234

1422

(3026470) Cobalt [Mass/volume] in Blood

195

947

1.96

17.28

2.0

1.9

4.1

3.4

ug/l

0.46

168

844

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

110

425

2.46

17.18

1.3

1.2

135.8

123.1

nmol/l

0.31

288

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

276

1501

1.75

17.10

1.0

1.1

279.9

490.0

mg/l

0.54

246

1347

(3020876) Protein [Mass/time] in 24 hour Urine

275

1505

1.74

16.68

1.9

2.0

0.7

1.2

g/24h

1.11

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1074

7785

1.32

16.43

2.1

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

495

3155

1.50

16.05

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

130

558

2.22

16.02

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.89

15.92

1.1

1.0

0.2

0.1

u/ml

0.59

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

161

3.37

15.77

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

137

607

2.15

15.62

1.1

103.9

86.4

5.51

275

(3011436) Histone Ab [Units/volume] in Serum

376

2.48

15.59

1.1

—

37.6

u/ml

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

476

3034

1.50

15.45

1.1

10.1

11.9

au/ml

0.28

206

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

885

6295

1.35

15.43

3.0

0.4

0.3

u/ml

1.37

520

3529

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

123

3.71

15.36

1.5

1.4

37.2

37.0

0.01

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

372

2250

1.58

15.35

2.6

3.4

6.2

8.1

nmol/l

0.31

361

2192

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

176

863

1.94

15.24

1.1

1571.6

1523.1

miu/ml

0.20

176

863

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

160

3.33

15.23

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

130

3.58

14.92

1.0

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

139

633

2.09

14.79

1.1

96.6

87.3

2.79

292

(3023420) DNA double strand Ab [Units/volume] in Serum

346

2079

1.59

14.70

1.5

1.6

31.6

38.7

iu/ml

—

(3045424) Erythrocytes [Presence] in Urine

497

3235

1.47

14.56

1.5

1.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

106

3.85

14.54

1.5

1.4

7.3

15.4

2.34

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

207

1089

1.81

14.44

1.3

1.2

442.9

442.6

titre

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

119

515

2.20

14.43

1.8

1.9

7.9

9.4

mg/l

2.17

100

412

(3025577) Chromium [Mass/volume] in Blood

183

927

1.88

14.40

2.0

2.4

2.3

ug/l

0.13

155

777

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

489

3187

1.46

14.24

1.2

3.9

3.7

u/ml

0.14

183

1443

(3038026) Centromere Ab [Units/volume] in Serum

268

1525

1.67

14.19

1.3

1.2

80.2

41.9

u/ml

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

139

644

2.05

14.15

1.2

1.1

119.1

106.1

2.53

122

585

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

202

1062

1.81

14.13

1.3

1.2

70.0

89.6

titre

0.30

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

261

1483

1.68

13.90

1.3

1.2

53.9

67.7

u/ml

0.34

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

966

7075

1.31

13.76

2.0

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

261

1488

1.67

13.74

1.3

1.2

38.8

48.2

u/ml

0.29

118

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

400

2525

1.51

13.66

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

444

2867

1.48

13.58

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

349

2.43

13.57

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

361

2244

1.53

13.27

2.3

2.0

25.4

26.9

mg/l

0.18

615

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

185

967

1.82

13.23

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

456

2977

1.46

13.20

1.6

1.7

—

(3037121) Protein [Mass/volume] in Urine

898

6578

1.31

12.80

2.8

3.2

0.3

g/l

0.17

375

2913

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

785

5646

1.33

12.76

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

245

1404

1.66

12.69

1.4

1.3

1.1

1.3

u/ml

0.22

124

610

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

238

1355

1.67

12.64

2.1

2.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

182

961

1.80

12.62

1.7

1.2

4.7

4.8

umol/l

0.08

167

886

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

247

1421

1.66

12.60

1.3

1.2

12.9

7.2

u/ml

0.35

101

(3006184) Hemoglobin [Mass/volume] in Capillary blood

617

4287

1.37

12.58

2.1

2.2

131.7

130.4

g/l

0.61

450

3065

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

490

3273

1.43

12.58

1.2

3.5

3.7

u/ml

0.09

137

1167

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

176

921

1.82

12.57

1.4

1.7

140.3

143.8

0.26

163

867

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

213

1180

1.72

12.52

1.0

256.7

359.8

ng/l

2.57

128

882

(3030313) Adrenal Ab [Titer] in Serum

132

3.31

12.49

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

346

2.36

12.44

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

245

1412

1.65

12.42

3.0

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

371

2355

1.50

12.39

1.7

2.1

5.6

7.6

umol/l

1.91

261

1739

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

421

2.21

12.18

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

213

1190

1.70

12.16

1.0

818.8

728.2

ng/l

1.59

123

856

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

213

1192

1.70

12.09

1.0

36.0

42.9

ng/l

1.72

124

880

(4306422)

473

3168

1.42

11.99

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

121

568

2.03

11.97

1.3

1.2

13.8

26.0

1.07

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

211

1184

1.70

11.86

1.3

1.2

91.4

89.0

u/l

0.12

181

1032

(3024869) Neuronal Ab [Presence] in Serum

280

2.48

11.74

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

140

699

1.91

11.62

2.2

2.0

8.7

10.1

0.89

135

648

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

424

2.18

11.58

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

132

647

1.94

11.58

1.4

14.6

15.1

pmol/l

0.47

115

555

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

226

1302

1.65

11.52

2.3

2.6

541.9

545.8

e6/l

0.03

196

1091

(3027923) C peptide [Moles/volume] in Serum or Plasma

186

1019

1.74

11.42

1.6

1.3

nmol/l

0.22

145

806

(3033923) Metanephrine [Moles/time] in 24 hour Urine

342

2.31

11.41

1.0

1.1

1.4

0.7

umol/24h

0.37

179

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

116

550

2.01

11.20

2.5

137.5

155.9

au/ml

0.14

(3048929) Epstein Barr virus Ab [Presence] in Serum

822

6062

1.30

11.19

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

208

1186

1.67

11.05

1.6

1.4

—

(3011412) CD3 cells [#/volume] in Blood

299

1861

1.53

11.02

2.3

2.4

1.3

1.1

e9/l

2.65

194

1110

(3034891) Synovial lining cells/100 cells in Synovial fluid

158

835

1.80

10.99

1.4

1.5

4.7

3.0

0.58

201

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

203

1152

1.68

10.99

1.3

1.2

28.3

23.3

u/l

0.66

171

988

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

143

734

1.85

10.93

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

428

2.13

10.93

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

247

1477

1.59

10.86

2.1

1.9

74.7

72.6

1.79

239

1426

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

217

1259

1.64

10.79

2.3

2.6

0.2

e9/l

0.06

194

1085

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

438

2.11

10.70

1.1

—

(3036180) Methadone [Presence] in Urine

7.24

10.69

5.1

3.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.24

10.69

1.3

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

208

1198

1.65

10.65

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.63

10.65

1.4

1.2

2.0

1.4

0.27

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

414

2.14

10.64

1.5

1.6

92.1

121.2

au/ml

0.34

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

984

7472

1.26

10.60

2.0

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

106

500

2.02

10.42

2.1

1.9

254.5

1038.9

e6/l

0.81

247

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

200

1148

1.66

10.39

1.9

2.1

104.4

97.0

2.08

181

1076

(43055514) Macroprolactin [Presence] in Serum or Plasma

102

476

2.04

10.33

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

649

1.88

10.21

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

122

610

1.90

10.15

2.8

3.1

6.8

8.3

mg/l

1.91

102

488

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

382

5103

0.71

10.13

1.3

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

241

1458

1.57

10.12

2.1

1.9

14.3

14.6

0.12

132

637

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

386

5141

0.71

10.06

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

386

5137

0.71

10.02

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

385

5125

0.71

10.01

1.3

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

139

731

1.81

9.88

1.6

30.1

29.6

umol/l

0.27

132

701

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

433

2.06

9.88

1.1

—

(1616796) Gas panel - Central venous blood

592

4249

1.33

9.87

3.3

3.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

271

1694

1.52

9.85

3.2

2.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

461

3186

1.38

9.83

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

278

1750

1.51

9.78

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

397

2.11

9.77

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

506

3557

1.36

9.70

1.1

3.4

4.6

u/ml

1.42

263

1757

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

573

4106

1.33

9.67

2.1

2.0

0.9

0.8

nmol/l

0.73

493

3438

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

133

697

1.82

9.58

2.7

2.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

232

2.46

9.57

1.4

1.3

42.9

54.2

1.06

118

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

272

1719

1.51

9.41

3.7

3.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

225

1365

1.57

9.38

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

250

1554

1.53

9.35

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

555

3979

1.33

9.35

2.5

16.6

16.5

0.28

303

2017

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

367

2.12

9.32

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

466

3257

1.36

9.29

1.1

22144.4

1103.6

iu/ml

0.47

100

689

(3047352) Trisomy 18 risk [Likelihood] in Fetus

311

4227

0.69

9.16

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

584

4231

1.32

9.15

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2463

20620

1.15

9.06

1.4

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

316

2.20

9.03

2.5

2.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

421

5421

0.73

8.95

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

312

4220

0.70

8.95

1.3

1.4

—

(3019977) pH of Arterial blood

170

975

1.66

8.94

3.4

2.4

7.4

0.15

357

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

157

885

1.69

8.82

1.1

182.7

186.6

iu/ml

0.05

157

875

(3012494) Peanut IgE Ab [Units/volume] in Serum

102

505

1.92

8.81

1.1

2.3

1.5

u/ml

0.18

268

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

441

3084

1.36

8.79

1.1

126.4

116.7

7.20

400

2793

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

408

2.03

8.77

1.5

0.4

ug/l

0.16

256

(3043238) Trisomy 21 risk [Likelihood] in Fetus

325

4336

0.71

8.63

1.4

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

111

572

1.85

8.50

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

430

3014

1.36

8.47

4.9

5.3

343.1

373.8

umol/l

4.59

385

2622

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

114

3.00

8.43

1.1

1.2

—

(3010421) pH of Blood

672

5017

1.28

8.43

3.7

3.8

7.4

0.00

557

4235

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

807

9472

0.80

8.41

1.4

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

266

2.25

8.31

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

341

2310

1.41

8.27

1.1

98.8

95.8

1.24

317

2167

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

365

2502

1.39

8.26

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

400

2791

1.37

8.13

1.1

1.5

g/l

0.44

364

2532

(3003694) ABO and Rh group [Type] in Blood

6733

59881

1.09

8.10

1.4

—

(4268621)

324

2184

1.41

8.10

2.2

2.3

—

(3017704) Immunofixation for Urine

154

886

1.65

8.06

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

789

6038

1.25

8.05

2.2

2.4

176.2

189.5

4.37

724

5720

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

320

2157

1.41

8.00

1.2

53.7

64.6

u/l

3.34

225

1430

(3028271) Lactate [Moles/volume] in Capillary blood

417

2940

1.35

7.94

2.0

1.8

1.7

1.8

mmol/l

0.94

411

2870

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

541

3960

1.30

7.93

1.1

2.1

1.4

u/ml

0.56

219

1499

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

359

2.04

7.93

1.3

1.2

0.7

48.5

mg/l

1.42

264

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

151

869

1.65

7.90

2.3

2.1

71.2

118.7

ug/min

0.54

202

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

329

2236

1.40

7.86

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

305

2047

1.42

7.83

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

155

901

1.64

7.80

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

116

1877

0.58

7.73

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

135

760

1.69

7.69

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

798

6154

1.24

7.61

2.5

3.7

3.6

g/l

0.35

749

5872

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

106

2.96

7.57

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

557

4120

1.29

7.57

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

478

1.87

7.56

1.3

1.2

40.3

39.3

g/l

0.33

258

(3005988) Vibrio sp identified in Specimen by Organism specific culture

348

2405

1.38

7.55

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

353

2446

1.37

7.53

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

470

3401

1.32

7.52

1.1

0.9

1.1

u/ml

0.31

193

1365

(3032057) Clostridioides difficile [Presence] in Stool

362

2.00

7.41

1.7

1.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

313

2132

1.40

7.41

1.1

2.1

iu/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

347

2405

1.37

7.40

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

352

2448

1.37

7.35

1.5

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

223

1429

1.49

7.34

2.4

2.6

834.2

721.0

e6/l

0.57

578

(4035726)

1799

19439

0.87

7.31

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

539

3994

1.29

7.24

2.7

3.6

264.0

886.8

u/ml

3.02

494

3636

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

225

1449

1.48

7.23

1.9

1.8

3.4

3.7

mg/l

0.69

214

1375

(3018133) Calcium [Moles/volume] in Urine

246

2.20

7.19

1.7

1.6

2.5

2.8

mmol/l

0.61

217

(3025468) Yersinia sp identified in Specimen by Organism specific culture

345

2404

1.37

7.14

1.5

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

342

2380

1.37

7.13

1.9

1.8

89.8

89.6

0.13

335

2347

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1594

0.57

7.09

16.0

17.9

1382.0

3461.8

nmol/l

1.05

1527

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

149

880

1.61

7.09

2.6

3.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

764

1.66

7.06

1.6

2.2

2.0

umol/l

2.37

120

716

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

118

657

1.71

7.04

1.1

—

(3004451) EKG impression Narrative

143

838

1.62

7.02

1.4

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

480

3520

1.30

7.00

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

183

1137

1.53

7.00

2.8

38.5

0.01

378

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

398

1.91

6.92

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

128

2.67

6.90

1.8

51.4

46.8

umol/l

0.32

128

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

312

2152

1.38

6.89

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

132

763

1.65

6.86

1.6

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

258

1725

1.42

6.83

1.1

1.3

—

titre

—

(40768800) Prostate Pathology biopsy report

289

3773

0.72

6.83

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

122

693

1.67

6.78

1.4

1.7

145.2

167.6

2.65

108

649

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

547

4105

1.27

6.68

5.4

6.1

9039.7

1156.7

iu/ml

0.45

654

(3007463) Buprenorphine [Presence] in Urine

3.63

6.65

9.0

5.7

—

(3027315) Oxygen [Partial pressure] in Blood

577

4362

1.26

6.63

3.7

3.9

8.6

kpa

0.02

565

4255

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

320

1.99

6.54

1.1

3.5

3.1

pmol/l

—

(4024509)

256

1727

1.41

6.48

1.6

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.98

6.46

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

164

1014

1.54

6.45

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1514

0.58

6.43

13.7

12.6

803.3

1498.7

nmol/l

0.54

1465

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

123

713

1.64

6.36

2.5

2.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

412

1.85

6.27

1.5

1.3

36.3

40.1

0.34

292

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

242

2.12

6.26

1.9

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

255

2.09

6.23

3.0

2.3

—

(3012501) Base excess in Blood by calculation

569

4337

1.25

6.13

3.7

3.9

2.5

mmol/l

0.29

411

2925

(3006442) Creatine [Moles/volume] in Serum or Plasma

215

1421

1.44

6.12

1.6

1.4

63.7

70.4

umol/l

1.76

108

(3013290) Carbon dioxide [Partial pressure] in Blood

569

4339

1.25

6.10

3.6

3.9

5.1

5.0

kpa

1.86

557

4232

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

205

1344

1.45

6.09

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1452

12060

1.15

6.04

2.7

3.5

51.8

53.5

u/ml

0.05

1383

11666

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

461

1.77

5.94

1.2

264.7

310.0

pmol/l

0.81

346

(3002256) Pathology report gross observation

3220

28070

1.10

5.88

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

296

2083

1.35

5.84

7.3

6.8

7.2

7.5

mmol/l

0.62

249

1697

(3039443) Prostate specific Ag panel - Serum or Plasma

318

3991

0.75

5.84

1.6

—

(3017569) Oxygen content in Arterial blood

134

812

1.57

5.81

2.0

2.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

189

1232

1.46

5.81

1.1

ratio

0.20

467

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

375

2736

1.31

5.77

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

2.22

5.76

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

196

1293

1.44

5.67

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

440

1.77

5.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

440

1.77

5.66

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

440

1.77

5.66

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

440

1.77

5.66

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

135

826

1.55

5.63

3.7

3.9

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

415

1.79

5.55

1.1

1.2

91.1

84.6

0.39

129

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

180

2.22

5.48

1.0

1.1

1.9

1.8

umol/24h

0.23

180

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

280

1975

1.35

5.48

4.0

5.0

224.5

93.8

u/ml

1.08

633

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

489

3715

1.25

5.47

2.9

3.2

—

(3000034) Microalbumin [Mass/volume] in Urine

249

1725

1.37

5.46

3.1

3.0

42.3

53.3

mg/l

0.34

182

1217

(3033942) Copper [Moles/time] in 24 hour Urine

2.99

5.46

1.0

1.1

0.4

0.8

umol/24h

0.52

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

324

2338

1.32

5.43

1.7

1.9

6604.4

3256.9

titre

—

111

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

971

1.50

5.41

1.6

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

173

1126

1.46

5.40

1.3

1.4

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.03

5.33

1.1

289.6

581.1

u/l

0.71

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

239

1655

1.37

5.27

1.1

1.2

142.9

187.9

titre

0.32

286

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

175

1150

1.45

5.21

1.3

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

114

684

1.58

5.21

1.3

1.2

0.3

0.6

g/l

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

431

1.74

5.19

1.1

1.2

111.3

106.3

0.63

405

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

103

604

1.62

5.17

1.7

2.3

0.8

1.2

ug/l

2.38

574

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

816

6566

1.19

5.15

2.0

2.1

94.6

91.5

3.46

752

6100

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

418

1.75

5.15

1.1

1.2

73.3

75.0

0.07

124

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

797

6401

1.19

5.15

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

198

1335

1.41

5.13

1.6

1.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1192

12917

0.87

5.12

1.7

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.87

5.11

1.3

1.5

0.2

0.0

u/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

324

2360

1.31

5.11

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

288

2064

1.33

5.10

3.6

3.4

—

(3042631) Mycobacterium sp identified in Specimen

338

2477

1.30

5.09

2.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.78

5.03

1.0

62.8

20.9

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.78

5.03

1.0

15.4

23.4

u/ml

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

237

1653

1.36

5.02

1.1

1.2

61.3

146.1

titre

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

394

2955

1.27

4.96

1.3

36.8

31.6

u/l

0.29

358

2553

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

116

2.46

4.95

1.1

16.2

13.7

nmol/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.11

4.89

1.6

2.6

1.2

3.3

mu/l

1.43

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2437

21150

1.10

4.89

3.0

4.3

13.3

25.9

ug/l

2.30

1923

16874

(3006922) Hepatitis E virus Ab [Presence] in Serum

212

1460

1.38

4.88

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

418

3166

1.26

4.86

2.2

2.8

361.2

6475.5

u/ml

1.13

173

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

261

1.93

4.85

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

103

617

1.59

4.78

1.1

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

140

898

1.48

4.76

1.1

1.0

97.4

96.5

0.14

107

716

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

290

2103

1.31

4.76

1.5

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

539

1.62

4.68

4.4

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

539

1.62

4.68

4.4

2.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

545

6245

0.82

4.67

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

492

3817

1.23

4.62

1.2

1.3

279.2

275.1

u/ml

0.10

320

2525

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

138

2.27

4.61

1.6

2.1

2.0

mg/l

0.05

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

187

1274

1.40

4.61

12.3

12.2

0.6

mmol/l

0.60

178

1154

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

171

1148

1.42

4.59

2.7

2.8

17.4

24.7

ug/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1172

0.61

4.55

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

3.86

4.51

1.0

—

1.4

—

(4015189)

469

1.64

4.35

2.0

2.1

—

(3020491) Glucose [Moles/volume] in Blood

215

1515

1.35

4.34

1.8

7.1

6.8

mmol/l

1.18

173

1064

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

142

2.21

4.34

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

424

3266

1.24

4.29

3.2

3.1

0.8

nmol/l

0.07

334

2522

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

187

2.03

4.27

1.1

1.2

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

0.8

1.5

mg/l

0.75

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

1.4

2.3

mg/l

0.64

100

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

2.3

2.1

mg/l

0.06

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

1.1

2.1

mg/l

1.15

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

0.9

mg/l

0.00

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

3.9

1.8

mg/l

0.49

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

2.2

2.5

mg/l

0.08

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

1.4

1.7

mg/l

0.34

101

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

137

2.22

4.26

1.6

3.4

3.5

mg/l

0.04

(3037556) Urate [Mass/volume] in Serum or Plasma

509

1.61

4.24

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

395

3024

1.24

4.24

1.1

1.9

2.9

u/ml

2.52

157

1571

(3017354) Segmented neutrophils/100 leukocytes in Blood

254

1843

1.31

4.20

3.0

3.3

58.4

58.3

0.01

155

1185

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

515

4057

1.21

4.19

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

446

1.64

4.15

1.1

—

(4281824)

208

2628

0.75

4.15

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

124

801

1.47

4.13

2.2

2.4

56.5

53.6

umol/l

0.41

101

669

(3001686) Cold agglutinin [Titer] in Serum or Plasma

318

1.76

4.13

1.3

1.4

179.3

222.2

titre

—

(3004809) Band form neutrophils/100 leukocytes in Blood

394

3027

1.24

4.11

3.0

3.3

1.2

1.5

1.01

286

2364

(3008116) Ketones [Moles/volume] in Urine by Test strip

361

1.71

4.10

1.2

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

237

1710

1.32

4.10

1.1

—

71.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

237

1.88

4.07

1.3

0.2

0.3

nmol/l

0.35

164

(3052592) Norovirus Ag [Presence] in Stool

362

1.71

4.06

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.71

4.06

1.1

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

333

3950

0.80

4.05

3.3

3.5

25.6

37.7

u/ml

2.65

322

3791

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

174

2247

0.73

4.03

1.2

—

(3013466) aPTT in Blood by Coagulation assay

105

2.35

3.97

1.0

1.1

34.4

38.0

2.35

(1002224) Polysomnography panel

1118

9408

1.13

3.95

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2186

19074

1.10

3.95

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

423

1.64

3.95

1.1

7.3

6.7

mg/g

0.26

398

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1336

0.66

3.94

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

427

3327

1.22

3.92

1.5

1.4

0.4

nmol/l

0.20

306

2575

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

254

1.83

3.91

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

100

2.37

3.90

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.43

3.86

1.2

1.1

80.8

89.1

nmol/24h

0.26

(3028717) Thiamine [Mass/volume] in Blood

182

1.98

3.83

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.24

3.83

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

192

1359

1.34

3.82

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.69

3.81

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

132

2.16

3.77

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

192

1366

1.34

3.70

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

143

974

1.40

3.63

1.5

1.6

5.1

5.3

mmol/24h

0.08

(3028679) Herpes simplex virus Ab [Presence] in Serum

153

1059

1.37

3.54

1.2

—

(3006462) Nitrate [Presence] in Urine

136

927

1.39

3.46

2.8

2.9

—

(3009015) Lactate [Moles/volume] in Synovial fluid

157

2.00

3.43

1.3

5.7

6.6

mmol/l

0.40

(3014271) Vancomycin [Susceptibility]

123

827

1.41

3.39

2.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

126

2.11

3.36

1.0

1.1

6.3

10.6

u/l

1.04

126

(3002523) Influenza virus A Ag [Presence] in Specimen

433

3436

1.20

3.35

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

664

1.46

3.35

1.5

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

421

1.58

3.32

2.2

2.6

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

146

2.02

3.32

1.3

4.5

15.9

pmol/l

7.15

123

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

429

1.57

3.30

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

158

1115

1.35

3.27

1.3

1.4

5.6

5.7

mmol/l

0.97

145

1048

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

270

1.72

3.25

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

432

3439

1.20

3.25

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

250

1.75

3.21

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

198

1448

1.30

3.20

1.4

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

403

1.58

3.19

1.2

1.3

47.6

69.6

mu/l

0.67

311

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

641

1.45

3.16

1.1

—

(4211845)

144

1008

1.36

3.15

2.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

368

2900

1.21

3.10

1.3

7.2

mmol/l

0.05

281

2093

(3008037) Lactate [Moles/volume] in Venous blood

511

4146

1.17

3.10

3.7

2.9

1.5

1.6

mmol/l

3.53

502

4067

(3043410) Blood group antigens tested for on Red Blood Cells

544

1.48

3.07

1.6

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

158

1.92

3.03

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

236

1779

1.26

3.03

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

124

854

1.38

3.02

2.1

2.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

610

1.45

2.98

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

134

938

1.36

2.96

1.1

1.6

8.2

u/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

336

2646

1.21

2.88

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

224

1.74

2.85

1.4

1.5

155.6

113.8

ug/l

1.18

182

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1213

0.70

2.84

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

120

835

1.37

2.78

3.0

2.9

—

(3036603) Volume of Urine

187

1387

1.28

2.77

1.6

2031.4

1928.1

0.38

313

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

234

1.70

2.74

1.1

1.2

—

(3000285) Sodium [Moles/volume] in Blood

220

1.73

2.73

1.1

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

513

4212

1.16

2.72

1.4

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

300

1.61

2.71

1.8

62.6

pmol/l

0.00

251

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.61

2.69

1.0

—

(3051651) Icteric interference index of Serum or Plasma

166

1218

1.30

2.69

3.7

3.9

—

(3042628) Porphyrins [Moles/volume] in Urine

7.91

2.65

1.2

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

266

1.64

2.63

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

411

3327

1.18

2.63

1.1

2.9

1.9

u/ml

0.57

104

777

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.72

2.63

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

143

1032

1.32

2.62

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

1025

1.32

2.60

1.4

1.5

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.37

2.57

1.0

1.1

0.0

0.7

mg/l

0.50

(3001964) Herpes simplex virus Ag [Presence] in Specimen

606

1.41

2.56

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.90

2.56

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

143

1037

1.31

2.55

1.4

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

108

2.02

2.54

1.4

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

276

1.62

2.54

1.1

0.0

0.3

u/ml

1.67

175

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

184

1.75

2.48

1.0

0.0

0.2

u/ml

1.52

109

(3036048) Francisella tularensis Ab [Titer] in Serum

446

1.47

2.45

1.2

224.0

623.3

titre

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

324

1.55

2.44

1.4

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

507

4199

1.15

2.43

1.4

13.6

20.6

u/ml

—

(40768793) Breast Pathology biopsy report

492

5351

0.87

2.43

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

171

1280

1.27

2.41

1.0

0.3

1.5

u/ml

2.37

322

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

238

1850

1.22

2.40

1.3

11.5

11.8

mmol/l

0.18

464

(21494434) Karyotype in Bone marrow

209

1603

1.24

2.39

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

640

1.38

2.36

4.4

6.4

25.6

25.0

mmol/l

0.79

573

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

127

918

1.31

2.34

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

127

918

1.31

2.34

1.2

1.5

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.29

2.34

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

268

1.59

2.33

2.3

3.3

4.0

ug/l

0.73

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

1161

1.28

2.32

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

247

1.61

2.29

2.5

3.1

39.2

41.5

umol/l

0.28

218

(3015183) Erythrocyte sedimentation rate

145

1073

1.28

2.26

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

100

1.99

2.26

1.0

1.1

377.8

49.9

u/l

0.50

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2531

25387

0.94

2.26

4.7

4.3

31.2

32.3

5.62

1831

17463

(3011897) Casein IgE Ab [Units/volume] in Serum

271

1.58

2.23

1.0

1.2

0.0

2.9

u/ml

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

141

1.82

2.23

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

232

0.41

2.23

3.2

7.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

511

1.41

2.23

2.0

1.9

54.8

38.8

u/l

0.27

455

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

519

1.41

2.22

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

197

2296

0.81

2.22

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.05

2.20

1.5

0.8

0.7

umol/l

0.51

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

468

3887

1.15

2.19

1.4

1.5

114.6

112.8

u/ml

0.11

127

875

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

176

1340

1.25

2.18

1.6

1.4

12.6

u/l

0.00

169

1300

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

131

962

1.29

2.18

1.7

1.9

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

115

1.90

2.17

1.0

0.0

1.8

u/ml

0.93

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

122

888

1.31

2.17

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

122

889

1.30

2.16

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

171

1.72

2.15

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

555

1.39

2.14

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

125

918

1.29

2.09

29.2

27.7

117.1

115.0

ug/l

0.15

111

751

(3029634) Reagin Ab [Titer] in Serum by VDRL

352

2875

1.16

2.09

1.9

2.2

2.5

8.9

titre

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

376

1.47

2.08

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

377

1.46

2.06

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

377

1.46

2.06

1.1

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

130

963

1.28

2.05

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

130

963

1.28

2.05

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

130

963

1.28

2.05

1.7

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

628

5347

1.12

2.01

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.65

1.99

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

710

1.32

1.99

2.9

28.0

29.1

umol/l

0.48

547

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

428

1.42

1.97

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

167

1284

1.24

1.94

1.6

1.5

4.3

6.0

u/l

1.06

603

(3022689) Creatine [Moles/volume] in Urine

568

1.35

1.90

1.4

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

121

1.80

1.89

1.9

1.4

384.3

316.4

umol/24h

0.53

121

(21494815) CD4 cells/100 lymphocytes in Specimen

224

1779

1.20

1.89

2.1

41.3

39.8

0.21

228

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

137

1625

0.80

1.88

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

323

1.47

1.86

1.2

1.4

81.5

111.9

ng/l

0.36

212

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

209

1.59

1.85

1.1

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

158

1.68

1.83

1.0

0.0

0.5

u/ml

1.23

115

(3019174) dRVVT (LA screen)

173

1.65

1.82

1.0

1.2

—

(36303858) Crystals [Presence] in Urine

3.02

1.77

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

175

1.63

1.75

2.5

0.8

1.0

mmol/l

0.49

120

(21494814) CD8 cells/100 lymphocytes in Specimen

107

794

1.28

1.72

2.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

259

1.50

1.72

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

176

1.62

1.72

1.0

0.0

0.1

u/ml

0.59

101

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.89

1.69

1.0

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

463

3921

1.12

1.69

3.9

3.0

7.4

7.6

mmol/l

0.79

454

3859

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

119

1.76

1.68

1.2

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

141

1.68

1.66

2.4

2.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.90

1.65

1.1

1.2

—

15.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

277

1.47

1.65

1.1

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.86

1.64

1.1

1.0

0.2

0.5

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

120

1.74

1.64

1.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

171

1.61

1.64

1.0

0.0

u/ml

0.01

(3020393) Adenovirus Ag [Presence] in Stool

164

1.62

1.63

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

135

1.69

1.62

2.9

2.3

—

(4133840)

611

1.31

1.59

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

603

1.31

1.59

2.6

3.4

—

(3044009) aPTT.lupus sensitive (LA screen)

181

1.57

1.56

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

594

0.70

1.56

1.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

144

1.65

1.55

2.2

3.3

16.8

60.8

pmol/l

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.45

1.54

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.98

1.54

1.0

1.1

155.7

242.0

pmol/l

—

(3003129) Base excess in Capillary blood by calculation

434

1.36

1.53

1.5

1.6

0.5

0.6

mmol/l

0.04

411

(3006270) Folate [Moles/volume] in Blood

204

1645

1.18

1.52

1.2

1.1

363.2

378.4

nmol/l

0.49

172

1387

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

109

1.74

1.51

1.1

1.0

0.0

1.4

u/ml

0.87

(40757373) Influenza virus identified in Isolate

355

1.39

1.50

1.9

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

117

1.70

1.48

1.2

1.5

—

(3000012) Reticulocyte production index

130

1008

1.23

1.48

1.4

1.5

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.90

1.48

1.2

1.6

1.8

2.6

0.77

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

171

1365

1.19

1.45

5.9

6.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

447

1.34

1.44

1.1

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.31

1.42

2.8

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

178

1.55

1.42

2.0

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

359

1.38

1.42

1.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

1948

17629

1.05

1.40

4.8

3.6

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.25

1.39

2.0

2.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

105

1.72

1.39

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

265

1.43

1.38

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.77

1.38

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

156

1242

1.19

1.38

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

117

906

1.23

1.37

1.8

1.9

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.97

1.36

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

282

1.41

1.35

1.0

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

1.34

0.0

4.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

108

832

1.23

1.33

3.4

5.5

1743.3

3389.7

mg/l

0.41

593

(3035880) pH of Pleural fluid

124

972

1.21

1.30

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

221

1.46

1.30

1.4

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

436

4566

0.90

1.30

1.4

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.90

1.29

1.3

1.4

435.7

513.1

nmol/l

0.23

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.77

1.29

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

164

0.52

1.29

2.0

2.4

129.4

404.8

umol/l

—

157

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

633

1.26

1.27

2.0

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

431

4506

0.91

1.25

4.3

3.0

21.3

27.1

mg/l

3.12

282

2844

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

287

1.39

1.25

2.9

3.2

—

(44806420)

560

1.27

1.23

2.2

2.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

366

0.67

1.21

2.9

3.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

332

0.66

1.21

1.3

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.64

1.21

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

305

1.37

1.21

1.8

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

312

3310

0.89

1.20

1.4

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

365

0.68

1.20

5.8

6.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

242

2021

1.14

1.20

3.1

3.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

291

1.37

1.17

1.0

1.1

0.0

0.8

u/ml

1.40

204

(1761482) Bacteria [#/volume] in Urine by Culture

570

4992

1.09

1.16

4.8

3.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

104

1.64

1.15

1.0

1.1

0.0

1.1

u/ml

1.50

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

137

1532

0.85

1.15

1.2

1.3

1.5

g/l

—

(3024316) Viscosity of Plasma

1.72

1.12

1.1

1.6

1.3

1.6

mpas

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.00

1.11

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.90

1.11

1.0

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.90

1.11

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

145

1176

1.17

1.09

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1039

0.82

1.08

1.3

1.4

26.6

31.3

nmol/l

0.87

948

(3007700) Barley IgE Ab [Units/volume] in Serum

1.70

1.08

1.1

1.0

0.1

0.7

u/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

107

1.60

1.05

1.0

1.1

—

(3034426) Prothrombin time (PT)

745

1.21

1.05

1.1

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

117

0.49

1.05

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

273

1.36

1.04

1.2

1.4

7.0

226133.3

nmol/l

1.46

222

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

464

1.27

1.04

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

266

2260

1.12

1.04

2.5

2.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

249

1.37

1.03

1.1

1.2

—

(3022475) Manganese [Moles/volume] in Blood

142

0.53

1.03

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

201

1.42

1.03

1.5

1.4

69.0

73.3

0.34

168

(3036005) Urine sediment comments by Light microscopy Narrative

2.26

1.02

1.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.26

1.02

1.6

1.4

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.90

1.02

1.0

198.4

262.8

u/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

615

5439

1.07

1.01

2.8

3.0

1.5

mg/l

0.35

556

5017

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

824

8305

0.94

1.01

1.5

1.7

3.8

3.5

mg/l

0.55

631

5777

(3003577) Lead [Moles/volume] in Blood

163

1.46

0.99

1.4

1.5

0.2

umol/l

0.26

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.71

0.98

1.0

0.1

0.2

u/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

260

1.35

0.98

1.4

1.2

1.8

1.3

mmol/l

0.19

158

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

657

1.21

0.97

1.9

1.6

58008.4

12015.9

u/ml

0.58

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

164

1.45

0.97

1.0

0.0

0.7

u/ml

1.53

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

1.52

0.97

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

270

1.34

0.94

8.3

8.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

111

1.54

0.93

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

820

7352

1.06

0.92

2.7

3.7

905.0

1944.5

u/ml

0.59

685

6326

(3014599) Egg white IgE Ab [Units/volume] in Serum

154

1278

1.14

0.90

1.0

0.5

2.2

u/ml

1.47

283

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.11

0.90

1.3

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

207

1.38

0.90

1.4

1.2

59.3

243.6

u/l

0.64

146

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

458

1.24

0.89

13.0

8.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

315

1.30

0.88

1.0

89.2

81.2

ug/l

0.49

257

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.79

0.87

2.6

3.4

—

(3016750) Collection duration of Urine

106

1176

0.86

0.87

2.3

2.2

484.9

500.5

min

0.77

896

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

375

1.27

0.86

6.8

5.8

63.1

69.9

0.89

300

(3051593) INR in Capillary blood by Coagulation assay

103

834

1.17

0.85

7.5

9.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

169

1.40

0.85

1.1

1.2

43.7

48.2

mg/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

597

5317

1.07

0.85

1.4

120.8

137.6

pmol/l

0.25

575

5189

(3034614) HLA Ag [Interpretation]

1.77

0.83

1.0

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

194

1.37

0.83

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

609

1.20

0.83

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

133

1102

1.15

0.82

1.1

19.4

26.2

u/l

0.86

102

854

(44806071)

277

1.30

0.82

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

107

1.51

0.82

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.73

0.81

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

261

1.31

0.81

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

133

1104

1.14

0.81

1.1

81.4

87.6

u/l

0.35

106

886

(3002331) Protein [Mass/volume] in Peritoneal fluid

449

1.23

0.78

1.2

1.3

26.0

25.6

g/l

0.08

349

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

124

1.45

0.78

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.78

0.77

1.0

1.1

1.2

2.8

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.16

0.76

1.0

1.1

—

(4146454)

245

2119

1.10

0.75

2.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

366

1.25

0.75

1.8

2.5

7.9

7.7

mmol/l

0.10

212

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.70

0.75

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

189

1992

0.90

0.75

1.6

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

158

1682

0.89

0.75

2.1

1.9

2.6

2.3

u/field

0.29

729

(3051101) Glucose [Moles/volume] in Cord blood

373

0.76

0.75

4.9

6.0

—

(3012441) Differential panel - Pleural fluid

184

1941

0.90

0.74

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

272

2367

1.09

0.74

1.0

0.5

u/ml

0.06

481

(3017509) Phencyclidine [Presence] in Urine

232

1.31

0.74

1.8

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

150

1.39

0.73

1.2

81.2

125.3

ug/l

1.18

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

129

0.59

0.73

1.0

—

(40768441) Liver Pathology biopsy report

183

1564

1.11

0.72

1.5

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

507

1.20

0.71

1.1

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.90

0.70

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

329

2896

1.08

0.69

1.1

6.6

3.8

u/ml

1.31

128

1086

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

210

1.31

0.68

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

210

1.31

0.68

2.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

210

1.31

0.68

2.6

2.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

311

2735

1.08

0.68

1.1

8.6

4.3

u/ml

1.08

127

1085

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

171

0.67

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

502

1.19

0.67

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

651

1.17

0.67

1.9

1.8

10684.3

11797.3

e6/l

0.07

345

(40765096) Chromosome analysis panel by Banding

581

1.18

0.66

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

137

1.39

0.66

6.6

4.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

212

1.30

0.65

3.4

3.1

1.4

1.0

mg/l

0.41

138

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

417

1.21

0.65

1.2

1.9

2.7

2.8

ug/l

0.04

261

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.51

0.64

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.51

0.64

1.2

1.3

—

(3001729) Color of Synovial fluid

138

1.38

0.64

1.2

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

175

1505

1.10

0.64

1.2

1.4

11.8

12.1

umol/l

0.24

167

1431

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

123

1037

1.13

0.64

5.3

6.6

461.8

3257.8

u/ml

0.52

237

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

106

1.43

0.63

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

110

921

1.13

0.63

1.1

10.8

7.1

u/ml

—

157

(3029396) Erythrocyte agglutination [Presence] in Blood

530

0.82

0.63

2.1

2.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

262

2689

0.92

0.63

1.3

1.4

3.1

3.7

ug/l

0.52

219

2335

(3026692) Albumin [Mass/volume] in Peritoneal fluid

506

1.18

0.62

1.2

1.3

13.6

13.5

g/l

0.04

398

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

180

1.32

0.62

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.70

0.62

1.0

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

754

1.15

0.62

1.9

2.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

164

1.33

0.61

1.0

0.0

1.7

u/ml

0.69

118

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

755

1.14

0.61

1.9

2.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.59

0.0

1.9

—

11.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

766

1.14

0.59

1.9

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

241

1.26

0.59

1.3

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

100

1.42

0.58

1.1

1.0

0.3

0.5

u/ml

—

(3012565) Volume of 24 hour Urine

120

1018

1.12

0.58

2.0

2.3

1971.0

1962.7

0.03

114

908

(3023487) Leukocytes [#/volume] in Peritoneal fluid

732

1.14

0.58

1.9

5924.4

2609.2

e6/l

0.26

489

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

819

0.87

0.57

2.3

2.5

133.1

157.0

nmol/l

1.38

717

(3014891) Appearance of Pleural fluid

251

0.76

0.57

1.9

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

377

0.81

0.56

3.9

5.4

—

(40768446) Kidney Pathology biopsy report

868

0.87

0.56

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.48

0.56

40.5

13.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

133

1138

1.11

0.56

1.8

1.7

2.5

u/field

1.03

832

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

338

1.21

0.55

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

119

0.64

0.54

3.1

4.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.44

0.53

9.6

8.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

366

1.19

0.53

2.0

6.1

32.9

54.3

u/l

—

155

(3045462) Protein/Creatinine [Ratio] in Urine

127

1.35

0.53

3.3

3.9

71.9

44.8

g/mol

0.26

115

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

319

2844

1.07

0.52

2.4

2.7

350.0

850.1

u/ml

0.59

308

2736

(3025130) Human papilloma virus identified in Specimen

359

3215

1.06

0.51

1.8

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

136

1.33

0.51

1.0

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

858

1.12

0.50

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

137

1426

0.91

0.49

1.5

1.6

8.4

7.7

mmol/l

1.49

862

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

104

1.37

0.49

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

326

1.19

0.49

1.3

1.2

2.1

1.7

mmol/l

0.49

189

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

221

1952

1.08

0.49

1.2

1.3

—

(4038314)

1.38

0.48

1.2

—

(40758292) HTLV I+II Ab panel - Serum

348

0.82

0.48

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.51

0.48

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

471

0.85

0.47

3.6

2.9

123.6

104.7

ng/l

0.15

199

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

409

4082

0.95

0.47

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

239

2415

0.94

0.43

2.4

2.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

132

1.29

0.43

2.2

1.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

1.58

0.42

1.0

—

51.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

288

1.19

0.42

1.4

1.6

—

(3045788) Cell count panel - Pleural fluid

194

1719

1.07

0.42

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

116

1.31

0.41

1.3

1.9

1.0

0.8

0.16

(3007919) Fasciola sp Ab [Titer] in Serum

1.48

0.40

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.48

0.40

2.6

1.4

2.3

2.1

mmol/24h

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.40

0.0

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

134

1.28

0.39

7.3

4.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

300

1.17

0.38

1.4

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

195

1737

1.07

0.38

1.4

1.3

6.3

mmol/l

0.01

181

1606

(3032352) Blasts [#/volume] in Cerebral spinal fluid

204

1.21

0.38

1.8

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

292

1.17

0.37

2.4

2.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

182

0.78

0.37

3.3

2.1

69.9

58.7

—

114

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

110

0.69

0.37

2.0

3.6

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.34

0.36

1.3

1.4

1.1

u/field

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

154

1364

1.07

0.36

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

128

1.26

0.35

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.39

0.35

1.7

1.3

—

(3042733) HLA Ab [Presence] in Serum

785

0.91

0.34

4.0

5.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

107

1101

0.92

0.34

1.6

1.7

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.36

0.34

1.2

1.4

—

1770.3

—

(3004775) Volume in Urine collected for unspecified duration

159

1610

0.94

0.34

2.4

2.3

628.7

686.1

0.97

115

1122

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

153

1359

1.07

0.34

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

394

1.13

0.33

14.4

8.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3634

34892

0.99

0.31

2.7

2.8

0.7

0.8

ug/l

9.33

2427

22086

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

101

886

1.08

0.31

1.6

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

244

1.17

0.31

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.29

0.31

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

632

1.10

0.30

1.4

1.3

53.8

62.1

1.09

521

(3023199) Leukocytes [#/volume] in Pleural fluid

244

2208

1.05

0.30

1.5

4774.5

2716.7

e6/l

0.68

181

1593

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

245

1.16

0.30

2.3

2.6

0.8

0.6

u/field

0.31

245

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.28

0.30

1.0

—

(3001556) Androgen free Index in Serum or Plasma

175

1.19

0.29

1.0

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

229

2280

0.95

0.29

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

132

1.22

0.28

1.1

1.0

0.1

0.2

u/ml

—

(3032868) Hemoglobin electrophoresis panel in Blood

176

1.19

0.28

1.5

1.6

—

(3044007) Cell count panel - Peritoneal fluid

591

1.09

0.27

1.8

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

114

0.75

0.27

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

131

1170

1.06

0.27

1.0

0.5

0.9

u/ml

0.28

148

(3023383) Lactate [Moles/volume] in Pleural fluid

528

1.10

0.27

1.3

3.2

3.3

mmol/l

0.08

490

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

293

1.13

0.27

10.6

10.0

5.2

5.1

mmol/l

0.04

293

(40765089) Chromosome analysis panel - Blood by G-banded

554

0.91

0.26

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

258

1.14

0.26

1.3

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

125

1.22

0.26

1.3

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

159

1588

0.95

0.25

1.4

1.3

77.6

77.8

pmol/l

0.00

496

(46235168) Fasting glucose [Moles/volume] in Blood

242

0.86

0.24

2.8

2.1

6.6

7.2

mmol/l

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.28

0.24

1.0

0.4

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

297

1.12

0.23

5.5

7.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

127

1.20

0.23

2.1

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

509

0.91

0.23

1.3

1.2

119.2

321.8

ug/l

1.22

278

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.76

0.22

6.7

5.6

19.5

17.2

mmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

163

1.16

0.22

1.3

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

1.22

0.22

2.6

8.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

822

1.06

0.21

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

120

1.19

0.20

1.1

0.9

1.2

u/field

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.23

0.19

1.0

0.3

u/ml

—

(3033799) Differential panel - Peritoneal fluid

651

0.93

0.19

2.1

1.9

—

(3024471) HLA-A [Type]

775

0.94

0.18

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.15

0.17

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

122

1.17

0.17

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

746

1.06

0.17

1.6

1.7

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.11

0.17

1.1

—

mmol/l

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.15

0.16

1.3

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

101

1004

0.95

0.16

36.8

34.8

7.4

ug/l

0.05

911

(3008536) Aspergillus sp Ab [Presence] in Serum

398

1.07

0.15

1.5

2.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

863

8081

1.01

0.15

1.5

1.4

—

(4212803)

151

1.13

0.15

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.80

0.14

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.79

0.14

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

218

2013

1.03

0.14

1.4

50400.3

47136.9

e6/l

0.07

135

1196

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

317

1.08

0.13

1.9

1.7

—

(40758358) Immune stain study

105

0.81

0.13

1.0

—

(3048879) Bone marrow aspiration report

533

1.05

0.11

1.5

1.9

—

(3024932) HLA-DR beta [Type]

752

0.96

0.11

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

100

1.14

0.10

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

136

1326

0.97

0.10

1.3

1.2

12.0

14.4

u/l

1.14

122

1225

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

275

0.93

0.10

1.3

1.4

13.8

13.4

0.02

139

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.04

0.08

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

1.07

0.08

2.0

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

330

0.95

0.07

1.0

1.3

—

(3045142) Bone marrow Pathology biopsy report

235

2196

1.02

0.07

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

158

1.08

0.07

1.6

1.4

—

11.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.87

0.07

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.83

0.07

1.0

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

738

1.03

0.07

1.1

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

186

1.07

0.07

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.05

0.07

1.2

1.1

289.0

257.7

nmol/l

—

(3013762) Body weight Measured

0.88

0.06

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

103

1.11

0.06

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

131

1.09

0.06

1.1

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

163

0.93

0.05

1.3

1.0

1.7

ml/s/173m2

0.66

104

(3012898) Urea [Moles/volume] in Urine

216

1.05

0.05

1.3

1.5

159.2

169.7

mmol/l

0.26

188

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

840

0.98

0.03

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

543

0.98

0.03

1.4

1.9

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

304

0.97

0.03

2.5

2.6

51.7

70.6

pmol/l

0.57

258

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

247

1.04

0.03

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

568

1.02

0.03

1.1

4.4

10.6

u/ml

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

173

1656

0.99

0.02

1.4

1.3

402.6

519.4

u/l

0.89

163

1579

(3001893) Eosinophils/100 leukocytes in Pleural fluid

542

1.02

0.02

1.4

1.3

2.8

2.4

0.13

454

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

149

0.96

0.01

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

363

1.02

0.01

2.7

2.5

38.3

58.7

mg/l

—

(3020650) Glucose [Presence] in Urine

562

1.01

0.01

1.5

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

261

2471

1.00

0.00

1.5

1.4

34.0

33.4

g/l

0.33

232

2225

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

441

0.99

0.00

1.6

1.3

25.2

22.0

0.32

371

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.04

0.00

1.0

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

173

0.99

0.00

1.8

2.2

—

(3025315) Body weight

183

0.99

0.00

4.5

4.4

—

(3010937) Rubella virus Ab [Presence] in Serum

119

0.96

0.00

1.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.7

—

(46236302) HLA-C [Type] by High resolution typing

0.97

0.00

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.99

0.00

1.0

1.1

—

(3013862) HLA-DP [Type]

0.94

0.00

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3025311) HLA-B [Type]

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

0.5

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.2

—

3.8

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.96

0.00

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.97

0.00

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.4

—

(40760409) HLA-A [Type] by High resolution

0.97

0.00

1.0

—

(40760410) HLA-B [Type] by High resolution

0.97

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SCIATICA and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SCIATICA	1.1 [1.01, 1.2]	0.037
Birth year	0.996 [0.99, 1.0]	0.339

During the follow-up period (1.1.1998 — 31.12.2019), 9165 out of 84331 females with M13_SCIATICA died.

Males

Parameter	HR [95% CI]	p-value
M13_SCIATICA	1.137 [1.04, 1.24]	0.004
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 8100 out of 60565 males with M13_SCIATICA died.

Mortality risk

Mortality risk for people of age

years, who have M13_SCIATICA.

N-year risk	Females	Males
1	0.089%	0.205%
5	0.619%	1.231%
10	1.596%	3.107%
15	3.285%	5.838%
20	5.772%	9.725%

Relationships between endpoints

↥

Index endpoint: M13_SCIATICA – Sciatica+with lumbago

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sciatica+with lumbago

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints